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INTRODUCTION 
Siddha system is an unique disciplinary system of medicine which emphasizes 
good lifestyles to maintain health. This system is identified with Dravidian culture 
Persons who have accomplished spiritual perfection are called Siddhars. They 
considered philosophy and medicine two sides of the same coin. 
Siddhars defined the laws of nature and gifted the world their knowledge about 
the universe. According to them .The entire universe is composed of two essential 
entitile,  Andam (Material universe) and Pindam (Human body).  
              Many have poured their hearts in beautiful lyrics to describe the supernatural 
forces, various ailments, diagnosis and treatment etc.. One of the greatest of these is the 
knowledge of cosmos by Thirumoolar a great siddhar. He writes 
                 “விளக்கினை ஏற்றி வவளினை அறிமின் 
         விளக்கிைின் முன்னை னவதனை மாறும் 
         விளக்னக விளக்கும் விளக்குனைைார்கள் 
         விளக்கில் விளங்கும் விளக்கவர் தானம”  
                                           திருமந்திரம். 
                From the above quotation it is evident that, with the aid of the light called 
knowledge, One can know about the universe and succeeds in this the grievances of his 
soul faces would change and helping him to find the real form of knowledge. The karma 
of his creation should be dismisses. 
Great Siddhar Thirumoolar 
            “மறுப்பதுைல் ன ாய் மருந்வதைலாகும் 
            மறுப்பதுள ன ாய் மருந்வதைச் சாலும் 
            மறுப்பதைி ன ாய் வாரா திருக்கு 
            மறுப்பது சானவயு மருந்வதை லானம” 
                                                  திருமந்திரம்                                                                 
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The cosmos is based on Humoral  theory (Thridoshas) which again founded on five vital 
elements,  Panchaboothas viz, prithvi ,Appu,Theyu,Vali,Veli.which plays a vital role in 
the mode of diagnosis ,investigation, treatment and prevention. Even the modern 
scientists are not able understand the ancient classification of diseases, parameters and 
mode of treatments it is beyond their knowledge how it works.      
 
     “Rf;fpyj;jpy; RNuhzpjk; fyf;Fkd;W 
    G+e;jpLk; tpahjp %d;W” 
                 -rpj;j kUj;Jthq;f RUf;fk; 
  
  Paediatric diseases are carried from gene.It defines that the paediatric diseases occurs at 
the time of fertilization to gestational period. Those paediatric diseases where classified 
in to Agakkarana noigal and Purakkarana noigal. 
Scabies is a contagious disease (SARCOPTES SCABEI) this disease is common 
in children. The symptoms of Sirangu are Nocturnal itching, Burrows, Pruritic papules, 
pustules, Papulovesicule. Seen in web of hand, wrist, axilla, buttocks, genital area are 
correlated to Scabies in modern medicine. 
Scabies affect 300 millions of people worldwide. The highest prevalence rate 
may be seen in children, 51% of the children aged 3-7 years being infected. 
Hence the author has undergone dissertation work about the clinical trail of Oma 
Legium(internal) and Musuttai Ennai(external) to prove its safety and efficacy against 
sirangu in children 
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AIM AND OBJECTIVE 
Aim: 
         The aim of this study is to evaluate the efficacy of the siddha medicine OMA 
LEGIUM (Internal medicine), MUSUTTAI ENNAI (External medicine) in the treatment 
of scabies. 
Objective: 
 To study the safety and efficacy of the trial medicine. 
 The main aim of present study on SIRANGU is to collect and make a detailed                  
study about the ideas mentioned in siddha concept based on literature. 
 To study SIRANGU in various literature in comparison with modern science. 
 Collection and detailed study of various siddha and modern literature dealing 
with aetiology signs, Symptoms, diagnosis, prognosis,  complication and 
treatment of  SIRANGU. 
 To study the 
  Acute and Sub Acute toxicity 
  Pharmacological steudies 
  Physicochemical analysis of the trial drug 
 To have trial on patient with the trial drug OMA LEGIUM (internal) and 
MUSUTTAI ENNAI (external) 
 Scabies can be prevented by avoiding direct skin to skin contact with an infected 
person. 
 Good personal hygiene is important to prevent and control scabies. 
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SIDDHA ASPECTS 
 DEFINITION: 
Kjypy; mhpg;Gz;lhfp> mt;tplj;jpy; Nth;f;FU Nghy; xd;W my;yJ gy 
FUf;fs; Njhd;wp mit rpwpa ePh;f; nfhg;Gsq;fshf khWtJk; rpy rkak; rPo      
nfhg;Gsq;fshf khWtJkhd ,ay;GilaJ.  
 Itching followed by one or more papules, this became change into vesicles and 
sometimes pustules. 
AETIOLOGY: 
According to Sirappu maruthuvam, 
 Due to excessive heat of the body the blood is infected to produce Sirangu. 
 A type of Kirumi causes Sirangu. 
Due to excess heat of the body, a type of Kirumi penetrates the muscle to produce 
Sirangu and also the excessive heat impure the blood results in pruritis and itching.  
CLASSIFICATION: 
In Sirappu Maruthuvam there are two types. 
1. Siru Sirangu: 
The lesions and burrows are small in a nature 
2. Perum Sirangu: 
The lesions and burrows are large which may be secondary infection. This is also 
called as Yaanai Sirangu. 
Another classification shows four types. The four types are, 
1. Adar Sirangu: 
Sirangu occurs densely in clusters. 
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2. Ottu Sirangu: 
Sirangu develops by close physical contact. 
3. Kilaitha Sirangu: 
The lesion develops adjacent to the primary one. 
4. Thutta Sirangu: 
 Patients suffer with Mega Noi and it is very difficult to treat. 
According to T.V.Sambasivam Pillai, 
Sirangu is classified into 6 types in T.V. Sambasivam Pillai dictionary. 
1. Aaanai Sirangu   –  Itching with red scaly patches 
2. Sori Sirangu   –  Itching with scales 
3. Namuttu Sirangu   –  Itching with pustules 
4. Thotar Sirangu   –  Confluent itching 
5. Perum Sirangu   –  Itching with wide vesiculation 
6. Parangi Sirangu   –  Syphilitic itch 
According to PulipaniVaidhyam – 500: 
Sirangu Classified into two types. 
1. Siru Sirangu 
2. Perum Sirangu 
The verse for this as follows, 
‘Neuhf gj;jpae;jhdpr; rhgj;jpak; 
epr;rakh iae;J  ehNsO ehshk; 
rPuhf jiyKOfp tUthahfpy; 
rpWrpuq;F ;ngUQ;rpuq;Fk; epy;yhNjhLk; 
Nguhf NghfUlflhl ;rj;jhNy 
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NgrpNdd; Gypg;ghzp NgrpNdNd.”   
         Gypg;ghzp itj;jpak; - 500 
SITES OF OCCURRENCE: 
According to Pararasa seharam, the commonly affected areas are Kai, Viral 
Idukkugal, Puttam, Araiidukkugal, Marmasthanam, Kongai etc. 
CLINCIAL FEATURES: 
‘rpWtDWq; ifj;jyj;jpw; Gwq;ifjd;dpw; 
NrWkiw Kjyhd kWjhdj;jpy; 
tpWtpnwdr; nrhwpe;Jjz;zPh; fl;bg; gpd;G 
kpFe;j jpdTz;lhf;Fk; tpspk;Gfpw;wha; 
,WFkpilrpWFE}jy; tiuNeh; nfhq;if 
apUtpopAk; gapdkiyap fDey;yha; 
fUTjy; NrUQ; rpuq;fpd; Fzkpnjd;W 
fl;Liug;ghh ;kiwAzh;e;jfhl;rpNah  
                             guuhrNrfuk; (ghyNuhfepjhdk;) 
 Pararasa seharam (Bala Roga Nithanam) describes the clinical features  
1. The lesions occur over the webs of fingers, wrist, inguinal region, buttocks etc. 
2. There is intense itching. 
3.   The lesions like vesicles filled with fluid. 
4.  The lesions may also occur over the waist, breast and near the eyes. 
In the text siddha Sirappu Maruthuvam, the clinical features of Sirangu are mentioned 
as,  
1. Itching 
2. Vesicles 
3. Pustules 
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4. Lesions commonly occur over the webs of fingers, toes, wrist, folds of 
axillae, penis, buttocks and inner part and thigh.  
MUKKUTRA VAERUPADUGAL : ( Pathogenesis) 
Disease occurs due to the derangement in 
  Uyir thathukkal  
  Udal thathukkal   
  Kala marupadu (seasonal changes) 
 Thinai( living lands )  
 Udal vanmai. 
UYIR THATHUKKAL: 
Mukkutra Iyal: 
The function of the three Uyir thathus:  
a) Aahaayam (space) + Vayu (air)   - Vatha 
b) Thee (Fire)                                   - Pitha 
c) Appu (water) + Prithivi (Earth)   - Kabha 
The alteration of three thathu in their reaction to extrinsic or intrinsic factors 
results in disharmony. This altered harmony and balance variation of the three thathus 
results in disease. Their natural ratio (1 :½:¼) to each other is discerned by the 
physician at the wrist and each nadi is individually assessed for its strength, speed and 
regularity. 
The following poem describes the origin of three Uyir Thathus 
   ‘,Ug;ghd ehb vOgNjhBuh 
apukhd Njfj;jpy; Vyg; -ngUehb 
xf;fj; jrkj; njhopiy a+f;f jrthAf;fs; 
jf;fgbahdNj  rhu;G” 
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‘rhUe; jrehb jd;dpy; %yk; %d;W 
NgUkplkp gpq;fiyAk; gpd;dYld;-  khWk;  
ciuf;ftpuw; fhw;nwhl;Lzu;j;J Nkehrp 
tiur;Rop Nahikaj;jpy; te;J” 
‘te;jfiy %d;wpy; tha;thkghdDld; 
je;j gpuhzd; rkhdDk; re;jKwf; 
$l;Lwtpy; Nurpj;jy; $Wk; thjk; gpj;jk;; 
ehl;Lq;fgNk ahk; ehL” 
fz;Zrhkpak;- gf;fk; 36 
The three Thathus are manifested at the wrist and are individually and 
collectively assessed. These three humour are divided in to various types and have their 
functions specifically. 
FUNCTIONS OF VALI:  
               ‘xOq;Fls; jhNjo;%r; Nrhq;fp ,aq;f 
vOr;rpngw vg;gzpAk; Mw;w - vOe;fpupa 
Ntfk; Gyd;fSf;F Nktr; RWRWg;G 
thfspf;Fk; khe;ju;f;F thA” 
  -kUj;Jt jdpg;ghly;  gf;fk;12 
According to the physiological function, vali is ten types. They are  
S. 
NO 
VATHAM GENERAL FEATURES 
CHANGES IN 
SIRANGU 
1. 
Piranan 
(Uyir Kaal)  
Responsible for respiration and it 
is necessary for proper digestion  
Normal 
2. 
Abanan 
(Kizhnokkukaal) 
Responsible for  all downward 
forces such as voiding of 
urine, stools, semen, menstrual 
flow  
Due to constipation 
Abanan was affect. 
3. 
Viyanan 
(Paravukaal) 
Dwells in the skin and is 
concerned with the sense of 
touch , extension and flexion 
of the parts of the body and 
distribution, of the nutrients to 
various parts of the body 
Viyanan was affect 
due to itching, skin 
colour changes and 
dryness. 
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4. 
Uthanan 
(Melnokkukaal) 
Responsible for all kinds of 
upward motion such as nausea, 
vomiting etc... 
Normal 
5. 
Samanan 
(Nadukkaal) 
Considered essential for 
proper digestion, assimilation 
and carries the digested 
nutrients to each and every 
organ 
Samanan was affect 
due to derangement 
of Viyanan and 
Abanan. 
6. Naagan  
Helps in opening &closing of 
eyelids 
Normal 
7. Koorman  
Responsible for vision, 
lacrimation  and yawning 
Normal 
8. Kirukaran 
Induces  appetite, salivation, 
all secretions in the body 
including nasal secretion and 
sneezing 
 
Normal 
9. Devathatthan  
Induces and stimulates a 
person to become alert, get 
anger, to quarrel, to sleep etc. 
Devathathan was 
affect due to itching 
at night (sleep 
disturbances)  
10. Dhananjeyan  
Resides in the cranium and 
produces bloating of the body 
after death. This leaves from 
the body after 3days of death, 
forming a way through the 
skull. 
 
 
In Sirangu – Abanan,Viyanan and Samanan will be mainly affected and 
Devathathan may also be affected. 
 
FUNTIONS OF AZHAL: 
 ‘grpjhfk; Xq;nfhspfz; ghu;itgz; lj;J 
 Urpnjup rj;jp ntk;ik tPuk; - crpj 
 kjp$u;j;j Gj;jptdg; gspj;Jf; fhf;Fk; 
 mjpfhup ahq;fh doy;” 
-kUj;Jt jdpg;ghly; gf;fk;16 
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Azhal is functionally divided in to five types. They are 
S.NO PITHAM NORMAL FEATURES 
CHANGES IN 
SIRANGU 
1. Anar Pitham 
Peps up the appetite and 
aids in digestion. 
Anar pitham was 
affect  due to loss of 
appetite 
2. Ranjaga Pitham 
Responsible for the colour 
and contents of blood. 
Ranjaga pitham was 
affect due to pallor 
3. Saathaga Pitham 
Controls the whole body 
and is held responsible for 
fulfilling a purpose. 
Normal 
4. Pirasaga Pitham  
Dwells in the skin and 
concerned with the shine, 
glow, texture and its 
complexion 
Pirasaga pitham is 
responsible for 
complexion of the 
skin.so it was affected 
in all cases 
5. Alosaga Pitham 
Responsible for the 
perception of vision. 
Normal 
 
In Sirangu- Anar Pitham, Ranjaga pitham and Pirasaga pitham may be affected. 
FUNTIONS OF IYAM: 
„jplkPA nkd;gpizg;Gj; jpz;ikAw;w ahg;Gk; 
mlNyu; tOtOg;Gk; Mf;iff; - fplu;f;F 
ntUthg; nghWikAk; Nkyhd fhg;ghk; 
ngUikj;jh ikankdg; NgR” 
-kUj;Jt jdpg;ghly; gf;fk;20 
S.NO KABHAM GENERAL FEATURES 
CHANGES IN 
SIRANGU 
1. Avalambagam 
Lies in the respiratory organs, 
exercises authority over other 
kabam and controls the heart 
and circulatory system. 
Normal 
2. Kilethagam 
Found in stomach as its seat, 
moistens the food, softens and 
helps to be digested. 
 
Kilethagam was due to 
loss of appetite 
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3. Pothagam 
Hold responsible for the 
sensory perception of taste. 
Normal 
 
   4. 
 
 
Tharpagam 
Presents in the head and is 
responsible for the coolness of 
the eyes, sometimes may be 
referred to as cerebrospinal 
fluid 
Normal 
5. Santhigam 
Necessary for the lubrication 
and the free movements of 
joints. 
Normal 
 
It is of five types. They are in Sirangu- Kilethagam may be affected. 
UDAL KATTUGAL (SEVEN PHYSICAL CONSTITUENTS): 
„,ukpuj; je;jir nea; epznkd;G kr;irtPe;njd;NwOk; KiwNa” 
rujnkhL nka;kdj;J epiwTjUk;capUl;Lj;jhq;fp apUf;Fk; 
 cuKjTk; NkLgs;sk; epuTk; nea;g; gira+l;Lk; Xq;fp epWj;Jk;  
gue;njd;gpd; JisfnlhWk; epuk;gpLq;fs; KisNjhd;wg; gz;Zk; 
njuptha;” 
                          -rpj;j kUj;J}thq;fr; RUf;fk; -gf;fk; 334 
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The human body is made of seven basic physical constituents. These constituents 
should be in harmony and function normally. Any variation in them will lead to their 
functional deviations. 
The Natural characters of the seven physical constituents 
S.NO UDAL KATTUGAL GENERAL FEATURES 
CHANGES IN 
SIRANGU 
1. 
Saaram 
 (Digestive essence) 
Responsible for the growth& 
development. It keeps the 
individual in good 
temperament and it enriches 
the blood. 
Saram was 
responsible for 
colour of the 
skin.so it was 
affected. 
2. Senneer (Blood) 
Responsible for the colour of 
blood and for the intellect, 
nourishment, strength, vigour 
and valour of the body.  
Senneer was 
affected due to 
skin colour 
changes 
 
3. Oon (Muscle) 
Gives lookable contour to the 
body as needed for the physical 
activity. It feed the fat next day 
and gives a sort of plumpness 
to the body  
Oon was affected 
due to burrows  
4. Kozhuppu (Fat) 
Lubricates the organs to 
facilitate frictionless functions. 
Normal 
5. Enbu (Bones) 
Supports & protects the vital 
organs, gives the definite 
structure of the body and 
responsible for the posture and 
movements of the body 
Normal 
6. 
Moolai (Bone 
marrow) 
Nourishes the bone marrow 
and brain which is the centre 
that controls other systems of 
body 
Normal 
7. 
Sukkilam/ 
Suronitham(Sperm/ 
ova) 
Responsible for reproduction Normal 
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KAALA MARUBADUGAL: 
PARUVAKALAM (SEASONS): 
Siddhars have classified a year into six seasons each constituting two 
months.There are some disease which are more prevalent during a particular 
paruvakalam and study of it will be of much useful for diagnosis. 
S. 
NO 
Perum Pozhuthugal              Suvai 
MUKKUTTRA   
MARUPAADUGAL 
1. 
Kaar Kaalam 
(Aavani&Purattasi) 
Aug16 to Oct 15 
Inippu,Pulippu,Uppu 
VATHAM-Vettunilai 
Vazharchi 
PITHAM-Thanilai 
Vazharchi. 
2. 
Koothir Kaalam. 
 (Iypasi &Karthigai) 
Oct 16 To  Dec15 
Inippu.Kaippu,Thuvarppu 
VATHAM- Thanilai 
Vazharchi 
PITHAM-Vettunilai 
Vazharchi  
3. 
Munpani Kaalam  
(Margazhi & Thai) 
Dec16 To Feb15 
Inippu,Pulippu,Uppu 
PITHAM- Thanilai 
Vazharchi  
4. 
Pinpani Kaalam  
(Masi & Panguni) 
Feb16 To Mar15 
 
Inippu.Pulippu,Thuvarppu 
KABHAM- Thanilai 
Vazharchi  
5. 
Elavenil Kaalam 
(Chithirai&Vaikaasi) 
April16 To June15 
Kaippu,Karppu,Thuvarppu 
KABHAM- Vettunilai 
Vazharchi  
6. 
MudhuvenirKalam 
(Aani& Aadi). 
June16 To Aug 15 
Inippu 
VATHAM- Thanilai 
Vazharchi  
 
THINAI (LAND): 
            Siddhars classified the lands in to five types. They are 
1. Kurunchi    - Mountain range 
2. Mullai         -Pastoral area of the forest 
3. Marudham -The fertile river bed 
4. Neithal      -The coastal region 
5. Paalai         - Arid desert                                               
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 The winter season gives good health to the man, early summer and latter rainy 
gives moderate health. Whereas early rainy and latter summer are more prone to 
diseases, that‟s why Siddhars called it as Aanaga kaalam 
 Marudham nilam is the fertile area where no disease occurs 
 
  
MUKKUTRA
M 
               PARUVAKALAM(SEASONS)                  
THINAI                         Thannilai 
Vazharchi 
(Accumulation) 
Vaetrunilai 
Vazharchi        
(Aggravation) 
Thannilai 
adaithal             
(Alleviation) 
 
 
VATHAM 
 
 
Muthuvenil 
kaalam 
 
 
Kaar kalam 
 
 
 
Koothir Kalam 
 
 
Vatham was 
predominant in 
neithal 
nilam.so it may 
aggravate the 
skin diseases. 
 
 
PITHAM 
 
 
Kaar kaalam 
 
 
Koothir kaalam 
 
 
Munpani 
Kaalam 
Pitha disease is 
more prevalent 
in Mullai land 
 
 
KAPHAM 
 
 
Pinpani Kaalam 
 
 
Elavenil kaalam 
 
 
Muthuvenil 
kalam 
Kapha disease 
is more 
prevalent in  
Kurunchi land 
 
RELATION BETWEEN MUKKUTRAM, KAALANGAL AND  
UDAL VANMAI (IMMUNITY): 
      Siddhars classify Udal vanmai as three types. They are 
1. Iyarkai vanmai 
2. Kala vanmai 
3. Seyarkai vanmai 
           Since Sirangu patients are suffering with principal symptom, we came to 
understand that it is because of alteration in Vali thathu and Vali should be the primary 
causative factor (Muthanmai kutram). It can be confirmed by the words of great Siddhar 
Therayer 
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PINIYARI MURAIMAI (DIAGNOSIS): 
           It means the method of diagnosing the disease.           
         ‘kjpj;jplw;fUik tha;e;j 
                   khz;gupfhunky;yhe; 
        Jjpj;jpl Tzu;e;jhNdDe; 
                  Jfswg; gzpapd;wd;ik 
        gjpj;jpl Tzuhdhfpw; 
                  gaDwhdhfhyhNd 
        tpjpj;jpL gpzpj;jpwj;ij 
                  tpsk;GJ Kjw;fz;kd;Ndh” 
                                      -rpfpr;rh uj;jpdjPgk;- gf;fk; 3    
The above poem describes that diagnosis is very important for the physician to 
treat the disease. 
Four steps are followed in diagnosing the disease. They are, 
a. Poriyaal arithal 
b. Pulanal therthal 
c. Vinaathal 
d. Envagai thervu  
In detail, 
a. Poriyaal arithal: 
                     In this the physician should carefully observe the changes that occur in the 
five sensory organs (Pori gal) of the patient. 
b. Pulanal therthal: 
The physician carefully applies his five senses of perception, smell, taste, vision, touch 
and sound to understand the condition of the patient. 
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c. Vinaathal: 
                 The physician should interrogate about the patients name, age, occupation, 
socio economic status, food habits, history of past illness, history of present illness, 
family history, 
ENVAGAI THERVUKAL 
                          ‘eh epwk; nkhop tpop ky%j;jpuk; 
                ehb guprkpit kUj;JtuhAjk;” 
           -Neha;ehly; Neha; Kjdhly;-253 
   த஡ொகுகலுற்று அட்ட஬ி஡ப் தரிட்சை ஡ன்சண  
              துனக்கப௃றும் தண்டி஡லன த஡பி஬஡ொகப் 
          தகுக்கரி஦ ஢ொடிச஦ ஢ீ திடித்துப் தொரு 
               தகர்கின்ந ஬ொர்த்ச஡ தொர் ஢ொச஬தொரு 
          ஬குக்கரி஦ ல஡கத஥ணத் த஡ொட்டுப்தொரு 
               ஬ப஥ொண ைரீ஧த்஡ின் ஢ிநத்ச஡ப்தொரு 
           ைகிக்கரி஦ ஥னத்ச஡ப்தொர் ைனத்ச஡ தொரு 
               ைொர்ந்஡ ஬ி஫ி஡சணப் தொர்த்து த஡பி஬ொய் கொல஠”. 
                               -கண்ணுைொ஥ி த஧ம்தச஧ ச஬த்஡ி஦ம். 
Nowadays advanced diagnostic tools have been developed by modern bio-
medical scientists. But Siddhars have given eight diagnostic methodological tools. They 
are called as Envagai thervu. 
Since Sirangu is due to the derangement of Vatham and pitham, the Neikuri will 
be Vatha or Pitha neer. 
 So Naadi does not play a vital role in the diagnosis of Sirangu in children. 
 In Sirangu the Sparisam may be affected due to the papules, pustule, itching. 
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Complications: 
 The verse is as follows, 
  ‘rpuq;fpd; kNfhjuf; fug;ghd; nrAq; Fze;jhd; 
   wpdtlq;fp tPq;fp ky ryKk; tw;wp 
   cuk;gapY Kjh KwTw; Kl;lhfp 
   Athjp kpFe;jhp Fuyha; kplWk; tpf;fp 
   tuk;gapW %r;R kpF Rthj Kz;lha; 
   thA kpFe;J}z; kwe;J jhfkpQ;rp 
   ,uq;FwNt fis Nrhf kpFjpAz;lh 
   apuhf; fhyj; jjpfhpf;F kpak;Gq; fhNy.” 
      - guuhr Nrfuk; 
Pararasa seharam says that Sirangu, if untreated can cause Mahothara karappan. The 
features are, 
 Itching gets reduced. 
 Oedema of the body 
 Oliguria 
 Impaired defecation 
 Hoarseness of voice 
 Dyspnoea 
 Loss of appetite 
 Polydypsia 
 These symptoms get exaggerated during night. 
NOI KANIPPU VIVAADHAM (DIFFERENTIAL DIAGNOSIS):  
                 1. Kalangakapadi 
                       2. Karappan 
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 : (Line of Treatment)  
In siddha system of medicine, the main aim of the treatment is to cure the 
disease by removing the root cause. Treatment is not only for perfect healing but 
also for prevention and rejuvenation.  
The entire siddha system of medicine consists of three great subdivisions namely,   
1) Noillaneri   (Preventive)  – Kaappu  
2) Noineekkuneri   (Curative methods)  – Neekkam  
3) Uramaakkumurai   (Strengthening methods)  - Niraippu  
Noillaneri is the special approach of the siddha system where regular dietary 
habit early rising, physical and mental disciplinarians are all emphasized. 
Prevention can mostly save our body and soul, but modernization results in 
alteration of good health, leads to disease.  
Siddha system is playing major role in treating and preventing many chronic 
diseases. Likewise, herbal medicines have several phyto chemicals which exert their 
beneficial effect on Sirangu 
The aim of treatment is    
 To bring the Mukkutram in equilibrium.  
 To treat the symptoms of the disease by internal medicines, external 
applications of medicated oil.  
A large number of medicines for Sirangu are stated in different literatures. Among 
them, an economically inexpensive and simple medicine  
1. Oma Legium (internal)   
2. Musuttai ennai (external) 
Diet:  
Avoid the  Brinjal, Kaar arisi,  maize, pearl millet, kodo millet, fox tail millet, 
Sesban, Bitter gourd, Pickles, Tamarind. 
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Prevention: 
Exclude people with scabies from childcare, preschool, school  until one day after 
treatment commences. 
All skin to skin contact and other people in the same household should be treated 
at the same time even if no itching or other symptoms are present.By the time scabies is 
diagnosed in one person, many other people may have been infested.If everyone is not 
treated at the same time treatment is likely to be unsuccessful. 
Underwear,clothing,towels,bed linen and personal effects such as 
slippers,dressing gowns and knee rugs used by the affected person in the 72 hours prior 
to treatment should be laundered using a hot wash cycle(hotter then 50◦c) or hot tumble 
dried to kill the mites. 
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SKIN ANATOMY 
The skin is the largest organ of the body. The whole surface of the body is 
covered by skin. It is a protective, elastic, waterproof and sensitive covering. In a normal 
person it is about 4kgs of weight and has about 1.75sq meters of surface area. The 
thickness of the skin varies from 0.5mm to 5mm. 
It has two layers, 
1, Epidermis 
2, dermis 
 
The Epidermis: 
     The epidermis is nonvascular. It is made up of stratified squamous epithelium. It 
has 4 layers in all places except palm and sole. In the palm and sole the epidermis has 
five layers. 
Thickness –About 0.1 mm for the ordinary skin . For the palm and sole it is about 
0.8-1.4 mm thick. 
The layers of the epidermis superficial to deep are, 
1 The Stratum Corneum 
2 The Stratum Lucidum 
3 The Stratum Granulosum 
4 The Stratum Germinativum. 
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The stratum corneum: 
   It is the Hornified layer containing keratin. It is the husky layer of the epidermis. 
On the palm and sole it is extremely thick. 
The stratum lucidum: 
It is transparent in nature. The cells are dying or dead already. It contains a 
pigment called keratohyalin. 
The stratum Granulosum: 
It has flattened cells. In the palm and sole it is thick. In other places it is thin. It 
contains the precursors of keratin. 
The stratum germinativum: 
Multiplication of cells of the skin takes place in this layer. This layer contains 
melanin pigment, which gives colouration for the skin. This layer is anchored to the 
dermis. 
The Dermis (or) Corium: 
        It contains fibrous and elastic connective tissue. It forms papillae projecting into 
the overlying epidermis. With in the dermis nerve, blood vessels and lymphatics are 
situated. Within the dermis fat is stored. 
       The surface of the dermis is made into small papillae. With in these papillae 
loops of blood vessels are seen. The dermal papillae contain nervous receptors like 
Meissner‟ corpuscles. Nerve endings carrying pain sensation are found plenty in the 
dermis. The dermis has arteriovenous anastomosis. This anastomosis helps in the 
regulation of the body temperature. The presence of large number of elastic fibres 
imparts elasticity to the skin. In old age this elasticity is lost, and elastic fibres are 
replaced by collagen fibres. This causes wrinkling of the skin. 
Within the dermis there are roots of hairs, numerous tubules of glands such as 
sweat and sebaceous glands are found .The coiled ducts of these glands open on the skin 
surface .There are two types of sweat glands namely 
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                   1. Eccrine glands 
                   2. Apocrine glands 
Eccrine Glands: 
  The eccrine glands are distributed all over the body. They are numerous on the 
skin of the palm, sole and head. They secrete watery sweat containing substances like 
lactic acid, urea and sodium chloride. 
Apocrine Glands: 
   The apocrine glands are distributed in the axilla around the nipple and female 
genitalia. They secrete an odourless secretion. The axillary odour is due to bacterial 
action on the sweat. These glands are induced by adrenaline. 
Sebaceous Glands: 
The sebaceous glands are small saccular glands. They are flask shaped and open 
in to the hair follicle. They are found abundant in the face, scalp, external nose, ear. They 
are absent in the skin of the palm and sole .These glands secrete a fatty secretion called 
sebum. The sebum keeps the skin supple. Plain muscle fibres called errectores pilorum, 
cause expulsion of the sebum in to the hair follicle and then to the skin surface. 
Ceruminous glands:  
   Ceruminous glands are modified apocrine type of sweat glands. They are found 
in the skin of the external ear. They secrete the ear wax. 
Appendages of the skin: 
   Sweat glands, hair, nails and sebaceous glands are considered as the appendages 
of the skin. Hair develope from epidermis but penetrates into dermis. Hairs are found all 
over the body expect on the skin of palm, sole and lips. The part of the hair which is 
visible is called shaft. 
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The hair follicle is formed by: 
1.Root of the hair 
2.Connective tissue covering  
3. Epithelial covering derived from  strattum  germinativum. The hair follicle is dilated to 
form hair bulbs. The hair bulbs are invaded by vascular knots. 
   Delicate strands of smooth muscles called erectors pilorum arise in the other part 
of the dermis and run obliquely to the middle of the hair follicle.These muscle causes 
erection of the hairs. In man it is responsible for the goose flesh appearance of the skin. 
The Nails: 
   The nails are horny plates firmly adherent to the dermis. The nails are situated in 
the nail bed. At the nail bed the dermis is arranged as ridges. The nail bed is profusely 
supplied with nerves and it is highly vascular. The proximal part of the nail is found in a 
groove skin called the nail groove. It is thinnest in this region. The white part of the 
proximal portion is the lunule. From the lunule the Nail Grow forwards. The body of the 
nail is firmly attached to the nail bed. The distal end is the free border. On either side the 
nail is bounded by a fold of skin called nail fold. 
Dermatomes: 
The area of the skin supplied by a single spinal nerve is known as a dermatome. 
The adjacent dermatomes overlap each other. So loss of cutaneous sensation in a nerve 
injury is less due to overlapping of the dermatomes. 
Langer’s lines: 
Presence of linear grooves and ridges on the skin . Surgical incisions may be 
performed along these lines,the langers line of cleavage. They tend to run longitudinally 
on the limbs and circumferentially on the neck and the trunk.  
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Vessels and Nerves: 
 Arteries form a network under the reticular and papillary layers.They send 
capillary loops in to the papillae 
 The veins form a superficial plexus under the papillae and also there are 
deeper venous plexuses. 
 Lymphatics begin as blind vessels or networks in the papillae and area 
deep to them. They drain in to a plexus at the junction of dermis and 
subcutaneous tissue.  
 Efferent nerves supply the smooth muscles blood vessels, erectors 
pilorum muscles and sweat glands. 
    Afferent nerve are connected with lamellar corpuscles, tactile corpuscles and hair 
follicles. They also form nerve endings in the dermis and epidermis. 
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SCABIES 
Definition: 
Scabies is a contagious disease and intensely pruritic skin infection caused by the 
host specific mite scarcoptes scabiei var hominis. (ectoparasite) an obligate human 
parasite (scabies means scratch). 
History of scabies: 
Known in animal as mange, the disease has been described since ancient times. A 
disease not unlike human scabies was described in the Old Testament and also by 
Aristotle in the fourth Century, However archaeological evidence and Egyptian 
hieroglyphics, suggests scabies has been irritating mankind for at least 2,500 years. 
Known in Europe by either the itch or gale, and common place in areas of filth and 
poverty, the disease was well-described. Celsus a physician of ancient Rome, coined the 
term “scabies” to describe this condition (2).”Scabies” is derived from the Latin word for 
“scratch”(scabere).The mite was described in early scientific treatises in 1100AD,but the 
connection to human disease was not made until 500 years later. 
      A physician, Giovan cosimo bonomo, described the mite in fluid expressed from 
the lesions of infested patients with the aid of microscopy. This description is notable for 
being one of the first accurate descriptions of parasitic Etiology of disease. Bonomo 
noted that puncture of the small, itching blisters that had not yet scabbed provided relief 
for those infected. He discovered a small, barely visible white speak within the blister 
secretions. Acreature with 6 legs, a sharp head, and “two little horns at the end of a 
snout” could be visualized. He found that most persons with chronic itch where infected 
by these undergo sexual creatures must reproduction. 
Bonomo also documented that the disease was easily spread, not only through 
mere contact of an infected person, but because the mites could survive outside human 
skin, and therefore lie in sheets, clothing and bedding.  
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TYPES: 
1. Human scabies.  
2. Animals scabies. 
PARASITOLOGY: 
 Classification-Sarcoptes scabiei var. hominis  
 Phylum-Arthropoda  
 Order-Astigmata 
 Class-Arachnida 
 Subclass-Acari 
 Family-Sarcoptidae 
 Genus and Species- Sarcoptes scabiei, variation hominis   
Life cycle: 
             Life begins with the eggs being laid in burrows in the upper epidermis, created 
by a mature female, of the host .The female will lay roughly 2 or 3 eggs per day in the 
burrow. These eggs will hatch after 3 to 4 days depending on the conditions of the 
burrow and the host, temperature is a big factor in hatching rate. Eggs are generally 
between 0.1 and 0.15 mm in length.The next stage is the larval stage and these are the 
form that hatch from the eggs. The Scabies larvae immediately begin to dig their own 
burrows close to the mothers burrow but closer to the skin surface, the larvae do not 
burrow as deep into the upper epidermis as the mother. The larval burrows are called 
„molting pouches‟ as they stay in their own individual molting pouch until they have 
molted into the next stage of the life cycle, the nymph stage. This molt into a nymph take 
about 4 to 5 days.The scabies nymph still stays within the molting pouch, or move to a 
hair follicle where they undergoes another molting process before the full adult morph is 
reached. The nymph undergoes one molt to become an adult and this takes roughly 10 
days but to  become a female adult mite it has to undergo two molts and this takes about 
17 days.Once a male adult has fully matured , it looks for a mature female in a molting 
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pouch and fertilises her and this only occur once in her lifetime, she is then fertile for the 
whole two months that she will lay eggs for. The life span of the female adult mites is 
only about 2 months, which is spent laying eggs, the male dies after copulation. The 
newly impregnated female leaves the molting pouch and searches for an area of skin on 
the host that is suitable for her to burrow into and lay her eggs. The area may be on the 
same host or she may be transferred to a new host. Skin that the females prefer are area 
that have folds or crevices suchas elbows, feet, fingers and genital area. The female than 
burrows into and horizontally through the upper epidermis to lay her eggs. The life cycle 
then begins all over again 
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TRANSMISSION: 
            Transmission occurs by prolonged close contact with an infected individual, but 
contact with clothing or bedding that has been infected by an individual. 
ETIOLOGY: 
          Sarcoptes scabiei the itch mites, is the causative organism. It is an oval, ventrally 
flattened mite. The female mite is 0.3 to 0.5 mm long. It is the fertilized female which 
burrows into the stratum corneum and there deposites her eggs. A few hours after the 
start of the burrow, egg laying begins; two or three eggs are laid daily continuously for 
nearly four to six weeks. The eggs hatch into larvae in three to four days. The larvae are 
transformed into nymphs, and these in turn into adults. 
EPIDEMIOLOGY: 
                 Scabies is usually contracted by close personal contact such as nursing an 
infested patient, overcrowding, close living quarters as occurs in institutionalized 
patients, or sleeping together and only infrequently by the common use of contaminated 
towels, bed linen, and clothing. The female can survive only two or three days away 
from warm skin. Arlian et al have reviewed the question of infestivity and survival of 
sarcoptes scabiei  in detail, and also the question of  cross infestation; they concluded 
that all varieties of the organism prefer certain hosts but do not insists on them. In a 
related study they found the mites respond to both host odor and thermal stumuli as a 
means of host- seeking behaviour. 
PATHOGENESIS: 
Mellan by points out that sensitization begins about two to four weeks after onset 
of infection. During this time the parasites may be on the skin and may burrow into it 
without causing pruritus or discomfort. Severe itching begins with sensitization of the 
host. In reinfection, itching begins immediately and the reaction may be clinically more 
intence. 
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NORWEGIAN  SCABIES: 
The lesions are so severe that the whole body and limbs including face, scalp and 
nails may be enveloped in crusts and scales in which large number of parasites are 
present. It is mainly seen in mental and geriatric patients and persists for years. 
ANIMAL SCABIES: 
  The acarus from cats and gogs rarely attack the human skin, as man is not a 
suitable host. The affection in such cases is usually transient. 
DIFFERENT IAL DIAGNOSIS: 
             The differential diagnosis depends on the types of lesions present. Burrows are 
virtually pathognomonic for human scabies. Papulovesicular lesions are confused with 
papular urticarial, canine scabies, chickenpox, dermatitis herpetiformis. Eczematous 
lesions may mimic atopic dermatitis, and the less common bullous disordes of childhood 
may be suspected in the infants with predominantly bullous lesions. 
CLINICAL FEATURES: 
Itching: 
The itching appears a few days after infestation. It may occur within a few hours 
if the mite is caught a second time. The itch is characteristically more severe at night and 
affects the trunk and limbs. It does not usually affect the scalp.   
Burrows:   
Scabies burrows appear as tiny grey irregular tracks between the fingers and on 
the wrists. They may also be found in armpits, buttocks, on the penis, insteps and backs 
of the heels. Microscopic examination of the contents of a burrow may reveal mites, eggs 
or mite feaces (scybala).     
Generalized Rash  
Scabies rash appears as tiny red intensely itchy bumps on the limbs and trunk. It 
can easily be confused with dermatitis and hives.The rash of scabies is due to an allergy 
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to the mites and their products and may take several weeks to develop after initial 
infestation.    
Nodules  
Itchy lumps or nodules in the armpits and groins or along the shaft of the penis 
are very suggestive of scabies. Nodules may persist for several weeks or longer after 
successful eradication of living mite.    
 Diagnosis  
Scabies can affect children, young adults and the elderly in every community, If 
you or your child developes a widespread itchy rash, especially if there's been close 
contact with another itchy person. However, not everyone who itches has scabies; 
dermatitis is not contagious.   If an itchy rash appears the diagnosis can be confirmed by 
microscopic examination of the contents of a burrow. That dermatologically only 
recovery of a mite or an egg in about 50% of cases of scabies  
INCLUSION CRITERIA: 
 Age: 3-7 yrs 
  Noctural itching Intense pruritis, particularly at night) 
 Burrows 
 Papules and papulo vesicles 
 Pustules 
 Lesions seen in webs of hands, Wrists, Ulnar aspect of forearm, Elbows, Axillae, 
Feet, buttocks, Palm and Sole, Genital area. 
 Patient having any four symptoms are included in my trail. 
EXCLUSION CRITERIA: 
 Glomerular acute nephritis 
 Eczzema 
 Photo dermatitis 
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 DIFFERENTIAL DIAGNOSIS: 
             The differential diagnosis depends on the types of lesions present. Burrows are 
virtually pathognomonic for human scabies. Papulovesicular lesions are confused with 
papular urticarial, canine scabies, chickenpox, dermatitis herpetiformis. Eczematous 
lesions may mimic atopic dermatitis, and the less common bullous disordes of childhood 
may be suspected in the infants with predominantly bullous lesions. 
 COMPLICATIONS:  
 ECZEMATIZATION 
It is one of the rare Complication of scabies. Scabetic areas may get sensitized. 
This sensitization results in Eczematization and well defined circular or oval patch of 
eczema consisting of erythema, oozing and crusting is formed. If there are severe patches 
the intervening skin is completely clear.  
IMPETIGINIZATION 
It is a rare complication of scabies. This is usually due to diminished local 
resistance. It starts as a superficial bullae containing seropurulent matter the contents 
coagulate to form a tick stuck on honey coloured crust. Crust is the most important 
feature of impetiginization. The lesion are usually multiple, the intervening skin is 
completely normal. Usually there is no pain or itch.  
 ACUTE GLOMERULONEPHRITIS  
Acute glomerulonephritis follows infection by streptococci on the scabetic areas. 
The onset is usually rapid, with puffiness around the eyes and edema over the feet. Urine 
colour is characteristically smoky brown, because of formation of acid hematin. The 
degree of oliguria usually correlates with the severity of the disease. Hypertension is 
usually present. A typical presentation may also be present which include, convulsions 
due to hypertensive encephalopathy the urine may grossly normal and edema absent. 
Left ventricular failure and pulmonary edema due to very high blood pressure, 
hypovolemia and acute renal failure. 
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PREPARATION AND PROPERTIES OF TRIAL DRUGS  
INTERNAL MEDICINE 
 OMA LEGIUM:                                                                                                                                                             
                    Ingredients: 
                   Omam (Tachyspermum ammi)                    - 3500 grms 
                   Amukura kizhangu (withania somnifera)  - 35 grms 
                  Kukil (shorea robusta) )                               - 35 grms 
                  Parangi patti (smilax china) )                      - 35 grms 
                   Karpoga arisi (psoralea corlifolia) )           - 35 grms 
                  Sugar                                                             - 350 grms 
                  Nei (ghee)                                                       - 2lits 
Source of raw drugs: 
           The required raw drug are procured from a well reputed indigenous drug shop and 
it will be authenticated by the Pharmacognosist, CRRI Chennai.    
Purification of raw drugs: 
           Raw drugs are purified as mentioned in Sikicharathna deepam Sarakku Suthi 
Muraigal. 
 Preparation: 
 Take 3500grams of omam(Tachyspermum ammi) and add 21.5 lit of water and 
allow to boil and bring it in 8 part and filter it. Then add 340grms of sugar to it make it as 
syrup form and add powdered form of amukura, kukil, parangipattai, karpogaarisi, each 
35grms and ghee 2 lits mix well in order to form a semisolid paste and preserve it in a 
clean container.   
Dose:      
 5 grms /twice a day (Internal )     
Duration:  14-21 days                      
   Ref:Aathmarakshavaitha sarasangiragam –pageno-446, 447                                                                                                                                                                             
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TRAIL DRUG 
INTERNAL MEDICINE  
 
 
 
 
 
 
 
 
 
Omam(Tachyspermum ammi)                                              Parangipatti(Smilax China) 
 
 
 
 
 
 
 
 
 
Amukkura Kizhangu(Withania Somnifera)         ( Karpokaarisi )  Psoralea Corylifolia 
 
         External Medicine  
 
                                                                      
 
 
 
    Kukil(Shorea Robusta)     Musutai(Rivea Ornata)   
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PROPERTIES OF TRIAL DRUG 
1.Omam 
Botanical Name: Carum copticum 
English Name: The bigshops weed 
Family:            Apiaceae 
Suvai:              Karppu 
Thanmai:         Veppam 
            Pirivu:             Karppu
ஓ஥ம் 
         ைீ஡சு஧ங் கொைஞ் தைரி஦ொ஥ந் ஡ம்ததொரு஥ல் 
        லத஡ி஦ிச஧ச் ைல்கடுப்பு லத஧ொ஥ம்-ஓ஡ிரு஥ல் 
        தல்தனொடுதல் ப௄னம் தக஥ிச஬ல஢ொ த஦ன்தைப௅ல஥ொ? 
        தைொல்தனொடுலதொம் ஓ஥த஥ணச் தைொல். 
Chemical Constituent: 
α-Pinene, β-Pinene,Carvacrol 
Actions:                    
                     Stomachic, Carminative, Antiseptic, Stimulant, Tonic, Sialogogue 
Pharmacological activities: 
                               Anti fungal, Anti oxidant,Antibacterial, Antiparasitic 
 2. Paranki pattai: 
Botanical Name: Smilax china 
English Name: china root 
Family:           Liliaceae 
Suvai:              Inippu 
Thanmai:         Thatpam 
Pirivu:              Inippu
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பரங்கி பட்டை: 
      ஡ொகம் தன஬ொ஡ந் ஡ொது஢ட்டம் புண்திபச஬ 
      ல஥டங் கடிகி஧ந்஡ி ஬ழீ்ப௄னந்- ல஡கப௃டன் 
      குட்சட தகந்஡ல஥ற் தகொள்஬஥ணம் லதொம்தநங்கிப் 
      தட்சட஦ிசண ப௅ச்ைரித்துப் தொர். 
Chemical Constituent: 
Betasitosterol, Beta-daucosterol, 3, 5, 4-trihydroxystibene, Isoengeletin, 
Engeletin, Kaempferol. 
Actions: 
Anti-syphilitic, Alterative, Aphordisac, Depurative. 
Pharmacological activities:  
Anti-inflammatory activity, Anti-psoriaticactivity, Anti-microbial action 
3. Amukkura- kizhangu: 
            Botanical Name: Withania somnifera 
English Name: Winter cherry 
Family: Solanaceae 
Suvai:Kaippu 
Thanmai: Veppam 
            Pirivu: Karppu 
அமுக்கிரா கிழங்கு 
      தகொஞ்ைந் து஬ர்ப்தொங் தகொடி஦க஦ம் சூசன஦ரி 
       ஥ிஞ்சுக஧ப் தொன்தொண்டு த஬ப்த஡ப்பு-஬ிஞ்ைி 
       ப௃சுவுறு ல஡ொடப௃ம்லதொ ல஥ொகம்அண லுண்டொம் 
        அசு஬கந் ஡ிக்தகன் நநி. 
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Chemical Constituent: 
Withanolids –A,Withaferin - A 
Action: 
            Deobstruent, Diuretic,Tonic, Soporific,  Sedative 
Pharmacological activities:  
Anti-stress, Anti-inflammatory activity,Anti-tumour 
Antioxidant, Immunomodulatory 
4. Kaarpoga arisi 
           Botanical Name: Psoralea corylifolia 
English Name: Babchi seeds 
Family: Fabaceae 
Suvai:Kaippu 
Thanmai: Veppam  
 Pirivu: Karppu 
கொர்லதொக அரிைி 
           கொர்லதொக ஥ொ஥ரிைி கண்டொற் க஧ப்தொன்புண் 
           தரீ்ைகு஬ ஢ஞ்ைிச஬லதொம் தித்஡ப௃ண்டொம்- தொர்஥ீ஡ில் 
           ஬ொ஡ கத஢ச஥ச்ைல் ஬ன்தைொநிைி ஧ங்கு஥றுஞ் 
           ைீ஡ ஥னர்க்கு஫னொய் தைப்பு. 
Chemical Constituent: 
                      Psoralidin, Psoralen, Flavonoids, Neobavaisoflavone, 
                       Isobavachalcone 
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Actions:   
Laxative, Stimulant    
 Pharmacological activities:  
Antiseptic,  Anti depressant, Anticancer,  Antiinflammatory, Antimicrobial  
5. Kungilium: 
  Botanical Name: Shorea robusta 
English Name: Sal tree 
Family: Dipterocarpaceae 
Suvai:Kaippu 
Thanmai: Veppam 
            Pirivu: Karppu 
குக்கில் 
          த஬ள்சப ஦பித்஡ ஬ி஧஠஢ொ திக்க஥னத் 
          த஡ொள்சப஬ி஧ ஠ம்ல஥கந் ல஡ொற்றுகினும்-உள்லப 
          ஬ரு஬஧ைசணல஥ற்புண் ஬ரினுஞ் சுல஬஡ச் 
          ைரு஬஧ை ல஥ற்த஫ிச஦ச் ைொற்று. 
Chemical Constituent: 
Non –triterpene, Asiatic acid, Tannic acid,Dipterocarpol 
  Actions: 
Stimulant, Diuretic, Expectorant 
Pharmacological activities:  
Analgesic activity, Antipyretic activity, Antibacterial, Anti  inflammatory,                                           
Antiulcer, Immunomodulatory 
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PREPARATION AND PROPERTIES OF TRIAL DRUGS 
EXTERNAL MEDICINE 
Musuttai Ennai:                                                                                  
Ingredients: 
Musuttai (Rivea ornata) 
Source of drugs: 
           The required  drug is procured from a well reputed indigenous drug shop and it 
will be authenticated by the Pharmacognosist, CRRI Chennai.    
Preparation:           
 Musuttai leaf ground then mixed with gingelly oil.Then boiled gently on fire till it 
attain.Then filter it stored in air tight container. 
Use:  External  use Only                                                                  
Ref : Gunapadam -Mooligai Vaguppu pg No:766 
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PROPERTIES OF TRIAL DRUG 
1.Musuttai: 
  Botanical Name: Rivea ornate, 
English Name: Night Glory 
Family: Convolvulaceae 
Suvai:Kaippu,karppu 
Thanmai: Veppam 
            Pirivu: Karppu 
ப௃சுட்சட: 
          ஥ொல஡ ப௃சுட்சட஦து ஬ொ஡த஥ொடு ஜ஦த்ச஡த் 
          ஡ீல஡ புரி஢ீச஧த் ஡ீர்க்குங்கொண் - ல஬஡சணதைய் 
          ஬ன்஥னத்ச஡த் ஡ள்ளூம் ஬நட்ைி தைொநிைி஧சகச் 
          ைன்஥஥நப் லதொக்கி஬ிடு ைொற்று. 
Chemical Constituent: 
Non –triterpene, Asiatic acid,Tannic acid,Dipterocarpol 
Actions: 
             Stimulant 
             Diuretic 
             Expectorant 
Pharmacological activities:  
                              Anti inflammatory 
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TRIAL DRUGS 
INTERNAL MEDICINE: 
OMA LEGIUM 
 
 
 
 
 
 
 
 
EXTERNAL MEDICINE: 
                                                         MUSUTTAI ENNAI 
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MATERIALS AND METHODS 
CLINICAL STUDIES:  
After finishing the toxicity studies 40 paediatric cases were selected on the basis 
of inclusion criteria from the OPD  of kuzhanthai maruthuvam Department, Arignar 
Anna Govt Hospital, Chennai-106 during the period of 2015-2017. 
The study was approved by Institutional Ethics Committee (IEC) and the 
approval number is GSMC-CH-ME-04/21/2015 
STUDY DESIGN & CONDUCT OF THE STUDY: 
             Study type:  
An open clinical study. 
Study place: 
 Arignar Anna Government Hospital of Indian medicine. 
                    Government Siddha Medical College. 
                     Arumbakkam, 
                   Chennai-600 106. 
            Study duration:  
12 months. 
Treatment period:  
14-21days 
Population and sample: 
    Population consist of paediatric patient attending the OPD of Arignar Anna 
Govt Hospital, Chennai-106. 
The sample consists of patients 3-7 yrs age group fulfilling all the inclusion 
criteria and exclusion criteria. 
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Inclusion criteria: 
 Age: 3-7 yrs. 
 Nocturnal itching. 
 Burrow. 
 Pruritic Papules.  
 Pustules.  
 Papulovesicles. 
Lesions seen in  
 web of hand , 
 wrists,  
 ulnar aspect of forearm, 
 elbow,  
 axillae, 
 feet,  
 buttock,  
 palms and sole 
 genital area. 
Exclusion Criteria: 
 Psoriasis 
 Papular utricaria. 
 Dermatitis herpetiformis. 
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Withdrawal Criteria: 
o Exacerbations of symptoms. 
o Intolerance to the drug and development of adverse reactions during the drug   
trial.      
o Any other acute illness.                                                                                                                     
Patients turned unwilling to continue in the course of clinical trial. 
Assessments and Investigations  
A. Clinical Assessment. 
B. Siddha Assessment. 
C. Laboratory investigations.                                                                                                                                                                                                               
Clinical Assessment 
 Nocturnal itching. 
 Burrow                                                                                         
 Pruritic papules  
 Papulovesicles. 
 Pustules. 
 Lesion seen in web of hand, wrist, aspect of foreman, elbow, axilla, feet, 
buttocks,palms and sole.           
 Nodular lesions in genital area. 
Siddha Assessment 
 Naa 
 Niram 
 Mozhi  
 Vizhi 
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 Sparisam  
 Malam 
 Naadi 
 Moothiram  
 Neer kuri, Nei kuri  
Laboratory Investigations 
Blood:  
             TC, DC, ESR, Hb. 
Urine: 
                Album, Sugar, Deposit. 
Methodology of Treatment: 
Study Enrolment: 
Patient′s parent or guardian reporting at the OPD  with child associated with 
clinical features of Nocturnal itching, Pruritus papules, Burrow, Papulovesicles, Pustules, 
Lesions seen in web of hand ,wrists, ulnar aspect of forearm of arm, elbow, axillae, feet, 
buttock,  palms, and sole, genital area. Are chosen for enrolment based on the inclusion 
criteria. The patients who are enrolled are informed about the study trial drug, possible 
outcomes and the objectives of the study in the language and terms understandable to 
them and the informed consent /Assent form would be obtained from the patient / 
patient‟s parent or guardian using consent/Assent form.  
Conduct of the Study: 
On the first day onwards the trial drug “OMA LEGIUM” (INTERNAL) 
&”MUSUTTAI ENNAI” (EXTERNAL) will be given. The trial drug will be given in the 
OPD department of Kuzhanthai Maruthuvam, GSMC, Chennai. The patients will be 
asked to have a regular follow up in the OP department once in 5 days. In each and every 
visit the clinical assessment will be recorded in the respective forms. The laboratory 
investigation will be done before and after treatment and recorded in the respective 
forms. 
45 
 
Data collection forms: 
            Required information will be collected from each patient by using following 
forms. 
Form I     :  Screening and selection Performa 
Form II    :  History taking proforma 
Form III   :  Clinical assessment Proforma 
Form IV   : Clinical assessment during and after trial 
Form V    :  Laboratory Investigation Proforma 
Form VI   :  Informed consent/Assent form 
Form VII  : Withdrawal form 
Form VIII : Patient information sheet  
FormIX     : Diet sheet 
Data Analysis: 
              After enrolling the patients in the study a separate file for each patient will be 
maintained and all forms will be kept in the file. Whenever the patient visits OPD during 
the study period necessary entries will be made in the assessment forms. 
The data entries and adverse events if any will be monitored by the Head of the 
Department. 
Outcome of Treatment 
Primary Outcome:  
                     Primary outcome is mainly assessed by comparing the reduction in clinical 
symptoms and   recurrence before and after treatment. 
 
46 
 
Secondary Outcome: 
Secondary outcome is assessed by comparing the safety parameters before and 
after treatment.                  
Adverse effect and Serious effect Management: 
              If the trial patient develops any adverse reactions the patient will be referred to 
the Pharmacovigilance department of SCRI and documented. For any adverse effect the 
investigator will give the proper management in the OPD. 
Ethical issues: 
1. Informed consent/Assent will be obtained from the patient / patient‟s parent 
or guardian after explaining about the clinical trial in an understandable 
language. 
2. After the consent of the patient (through consent/Assent form) if they fit in 
the criteria they will be enrolled in the study. 
3. Treatment will be provided free of cost. 
4. Concomitant medicines will be used if there is any need. 
5. The patients who are excluded (as per the exclusion criteria) will be refer to 
OPD. 
 
 
 
 
 
 
 
47 
 
RESULTS AND OBSERVATIONS 
The factors considered for the purpose of the study comprised of the following: 
 Sex Distribution 
 Age Distribution 
 Socio economic Status 
 Family History 
 Aetiological Factor 
 Food habits 
 Symptoms 
 Paruvakalam 
 Thinai 
 Classifications of results according to Vali, Azhal& Iyyam 
 Udal Kattugal 
 Ennvagaithervu 
  Naadi 
 Classification on the basis of Neikuri 
 Clinical progress 
 Results after treatment
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Female
57.5%
male
42.5%
SEX
Male
Female
1. Sex Distribution: 
S.No Sex No. Of Cases Percentage 
1. Female 23 57.5% 
2. Male 17 42.5% 
 
 
 
 
 
 
 
 
 
 
Inference: 
Among the 40 patients selected for this study, 57.5% were female children and 
42.5% were male children. 
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2. Age Distribution: 
S.No Age No. Of Cases Percentage 
1. 3-5 Years 21 52.5% 
2. 6-7 Years 19 47.5% 
 
 
 
Inference: 
Among the 40 patients, maximum numbers of patients 52.5% were in the age 
group of 3 to 5 year and 47.5% were in the age group of 6 to 7 years,  
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3. Socio-Economic Status: 
S.No Economic Status No. Of Cases Percentage 
1. Poor 28 70% 
2. Middle 12 30% 
3. Rich 0 0 
 
 
Inference: 
Among the 40 patients, 70% were poor status, 30% were in middle status 
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4. Family History: 
S.No Family History No. Of Cases Percentage 
1. Positive 14 35% 
2. Negative 26 65% 
 
 
Inference: 
Among the 40 patients, 65% of the patients showed negative family history, 35% 
patients showed positive family history 
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5. Aetiological Factor: 
S.No Aetiological Factors No. Of Cases Percentage 
1. Poor Hygiene 15 37.5% 
2. Contact from infected person 18 45% 
3. Over Crowding 0 0 
4. Poverty 7 17.5% 
 
 
Inference: 
Among 40 patients, 45% of the patients showed contact from infected person, 
37.5% of the patients showed poor hygiene and 17.5% of the patients showed poverty. 
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6. Food Habits: 
S.No Food habit No. Of Cases Percentage 
1. Vegetarian 4 10% 
2. Mixed 36 90% 
 
 
Inference: 
Among the 40 patients, 90% of the cases were mixed diet and 10% of the cases 
were vegetarian. 
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7. Paruva Kaalam: 
 
S.No Paruva Kaalam No. Of Cases Percentage 
1. Kaar Kaalam 5 12.5% 
2. Koothir Kaalam 10 25% 
3. Munpani Kaalam 6 15% 
4. Pinpani Kaalam 6 15% 
5. Elavenil Kaalam 5 12.5% 
6. Muthuvenil Kaalam 8 20% 
 
 
Inference: 
 Among the 40 patients,12.5% reported in kaarkaalam and Elavenilkaalam, 25% 
reported in koothir kaalam,15% reported in munpanikaalam and pinpanikaalam ,20% 
muthuvenilkaalam. 
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8. Thinai: 
S.No Thinai No. Of Cases Percentage 
1. Kurinji 12 20% 
2. Mullai 0 0 
3. Marutham 0 0 
4. Neithal 28 70% 
5. Paalai 0 0 
 
 
Inference: 
Among 40 the patients, 70% of the patients were from neithal, 20% of the 
patients were from Kurinji. 
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9. Uyir Thathukkal-Vatham 
S.No Vatham No. Of Cases Percentage 
1. Pranan 0 0% 
2. Abanan 11 27.5% 
3. Udhanan 0 0% 
4. Samanan 40 100% 
5. Viyanan 40 100% 
6. Nagan 0 0% 
7. Koorman 0 0% 
8. Kirukaran 8 20% 
9. Devathathan 3 7.5% 
10. Dananjeyan 0 0 
 
 
 
 
 
 
 
 
 
Inference: 
 Among the 40 patients, Samanan and Viyanan affected 100%, 27.5% affected 
Abanan, 20% affected Kirukaran, and 7.5% affected Devathathan  
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10. Uyir Thathukkal-Pitham 
S.No Pitham No. Of Cases Percentage 
1. Anarpitham 8 20% 
2. Ranjagam 8 20% 
3. Sathagam 0 0 
4. Alosagam 0 0 
5. Prasagam 40 100% 
 
 
 Inference: 
 Prasagam was affected in all the 40 cases, Anarpitham and Ranjagam was 
affected 20% of the patients and prasagam was a affected 100% of the patients. 
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11. Uyir Thathukkal-Iyyam 
S.No Iyyam No. Of Cases Percentage 
1. Avalambakam 0 0 
2. Kilethagam 8 20% 
3. Pothagam 0 0 
4. Tharpagam 0 0 
5. Santhigam 0 0 
 
 
 
Inference: 
Among the 40 patients, 20% of Kilethagam was affected. 
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12. Udal Kattugal: 
S.No Udal Kattugal No. Of Cases Percentage 
1. Saaram 40 100% 
2. Senneer 40 100% 
3. Oon 40 100% 
4. Kozhuppu 0 0 
5. Enbu 0 0 
6. Moolai 0 0 
7. Sukkilam 0 0 
 
 
 
Inference: 
 Among the 40 patients, Saaram, Sennar, and Oon was affected all the 40 cases. 
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13. Envagai Thervugal: 
S.No Envagai Thervugal No. Of Cases Percentage 
1. Naa 8 20% 
2. Niram 40 100% 
3. Mozhi 0 0% 
4. Vizhi 0 0% 
5. Sparisam 40 100% 
6. Malam 12 30% 
7. Moothiram 0 0% 
 
 
Inference: 
Among the 40 patients affected. Niram and Sparisam was affected 100% ,Malam 
was affected 30% and Naa was affected 20%. 
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14. Naadi: 
S.No Naadi No. Of Cases Percentage 
1. Vatha pitham 24 60% 
2. Pithavatham 16 40% 
 
 
Inference: 
Among the 40% patients Vaathapitham60% and Pithavaatham 40%. 
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15. Neikkuri: 
S.No Neikkuri No. Of Cases Percentage 
1. Vatham 22 55% 
2. Pitham 6 15% 
3. Kabam 12 30% 
 
 
Inference: 
Among the 40 patients, 55% cases were having VathamNeikkuri, 30% cases were 
having kabam Neikkuri, and 15% cases were having Pitham Neikkuri. 
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16. Clinical Features: 
S.No Clinical Features 
Before Treatment 
No. Of Cases 
After Treatment 
No. Of Cases 
1. Nocturnal itching  40 3 
2. Burrows 40 2 
3. Pruritic Papules 30 3 
4. Pustules 27 0 
5. Papulo vesicules 17 0 
 
 
Inference: 
Among the 40 patients. 100% of cases have Nocturnal itching and Burrows. 
75% of cases have Pruritis papules, 67.5% of cases have pustules, and 42.5% of the 
cases have Papulo vesicles. After treatment 7.5% of cases have Nocturnal itching and 
Pruritic papules, 5% of cases have Burrows. 
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17. Site of Infections: 
 
S.No Site of Infections No. of Cases Percentage 
1. Webs of the Finger 40 100% 
2. Buttocks 9 22.5% 
3. Groin 1 2.5% 
4. Around the axilla 0 0 
5. Peri umbilical region 0 0 
6. Joints(knee/Ankle) 0 0 
 
 
 
Inference: 
Among the 40 patients, 100% Lesion seen in web of finger,22.5% Lesion seen in 
buttocks and 2.5% Lesion seen in Groin. 
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18. Result: 
 
S.No Result No. Of Cases Percentage 
1. Good 26 65% 
2. Moderate 7 17.5% 
3. Mild 7 17.5% 
 
 
 
Inference: 
Among the 40 patients, 65% show good improvement, 17.5% Shown moderate 
improvement, 17.5% show mild improvement. 
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LABORATORY INVESTIGATION REPORT OF THE PATIENTS 
Si .No. 
 
OP No  Name  
Age/ 
Sex   
 HAEMATOLOGICAL ANALYSIS    
Urine analysis  
Before treatment  After Treatment  ESR (mm)  Hb (gms %)  
TC  
(cu/mm) 
DC  
TC  
(cu/mm) 
DC  BT  AT   BT  AT  
P %  L% E %  P %  L% E %  ½ 
hr 
1 hr ½ 
hr 
1 hr 
BT  AT  
Alb Su 
g 
Dep Alb Sug Dep 
1  9542 Vishali 3/FC  9800 43 51 6 9700 45 52 3 6 12 5 10 10.2 10.4 N N N N N N 
2  9541 Visvanathan 4/MC  14500 55 37 8 11000 56 40 4 32 58 15 34 11.9 12 N N N N N N 
3  9963 Rumarleeka 3.5/FC  12100 46 45 9 9900 53 43 4 22 39 13 20 12.3 10.1 N N N N N N 
4  8268 Vikneshvaran 7/MC    9100 67 27 6 8600 68 28 4 24 50 12 30 11.6 11 N N N N N N 
5  2143 Francy 7/FC  9900 56 37 7 9000 59 38 3 20 45 12 26 12.9 13 N N N N N N 
6  2273 Sanjay Kumar 3/MC  10800 47 48 5 8900 50 46 4 16 25 11 17 12.6 12.8 N N N N N N 
7  4309 Mohana 5/FC  6700 44 50 6 6500 48 49 3 10 25 7 16 11.6 12 N N N N N N 
8  5028 Janani 7/FC  7700 41 53 6 7400 50 48 3 14 20 8 13 11.6 11.8 N N N N N N 
9  6205 Yugalakshmi 6/FC 5500 48 47 5 4900 51 46 3 13 40 7 21 10.9 11 N N N N N N 
10  6081 Chinidini 6.5/FC  7400    67 30 3 6600 65 32 3 23 45 14 25 12.2 12 N N N N N N 
11 7470 Jeevanandan 7/MC 7500 47 45 8 7100 49 47 4 4 7 5 10 10 12.3 N N N N N N 
12 7478 Dayalan 4/MC 8600 56 36 8 8200 59 38     3 8 18 6 15 10.3 10.6 N N N N N N 
13 7405 Seetha 4/FC 7800 47 45 8 7900 50 46 4 4 10 3 8 11.8 12 N N N N N N 
14 7187 Dhivyasri 3/FC 13100 58 36 6 12300 60 37 3 5 14 6 13 12.4 12.2 N N N N N N 
15  3634 Nithishraj 4/MC  8300 45 50 5 7700 47 49 4 5 12 4 10 12.2 12.3 N N N N N N 
16  5903 Sandiya 7/FC  9100 44 47 9 8400 47 48 5 10 22 5 14 11.8 12 N N N N N N 
17  6601 Jeevika 7/FC  6300 44 47 9 6400 52 44 4 6 18 5 12 11.1 11.3 N N N N N N 
18  5057 Karthik 4/MC  7400 51 44 5 7100 52 45 3 3 5 3 4 10.7 10.8 N N N N N N 
19  
 
9619 Thaniyala 3/FC  8300 43 48 9 7500 46 49 5 5 15 4 13 10.5 10.6 N N N N N N 
20 8196 Dinesh 7/MC 10,000 71 22 7 8300 76 26 4 12 20 7 12 10.8 11 N N N N N N 
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LABORATORY INVESTIGATION REPORT OF THE PATIENTS 
 
Sl No  
 
OP  No  Name  
Age/ 
Sex   
 Haematological analysis    
Urine analysis  
Before treatment  After Treatment  ESR (mm)  Hb (gms %)  
TC  
(cu/mm) 
DC  
TC  
(cu/mm) 
DC  BT  AT   BT  AT  
P % L% E % P % L% E % ½ 
hr 
1 
hr 
½ 
hr 
1 hr BT AT Alb Sug Dep Al 
b 
Sug Dep 
21  5202 Asmitha 4/FC  9700 65 30 5 9100 66 31 3 10 18 5 12 11.9 12 N N N N N N 
22  6133 Srija 7/FC  11700 57 38 5 9300 52 42 6 3 10 3 8 11.4 11.4 N N N N N N 
23  6741 Sachin 7/MC 7200 58 35 7 6600 61 36 3 5 18 3 7 12.8 12.6 N N N N N N 
24  6989 Dharun 4/MC  8500 53 38 9 7800 56 40 4 4 7 4 5 10.5 11 N N N N N N 
25  129 Mageshwari 7/FC  8700 52 40 8 7900 58 38 4 4 10 3 8 12.5 12.8 N N N N N N 
26  959 Kirthika 5/FC  5800 52 40 8 7100 54 42 4 4 15 3 12 12.3 12.6 N N N N N N 
27  4643 Sathana 5/FC  9900 62 31 7 7600 65 32 3 12 18 6 12 10.2 10.8 N N N N N N 
28  5812 Charumathi 7/FC 9900 48 47 5 7000 53 44 3 12 20 8 10 11.7 11.9 N N N N N N 
29  5975 Dhanush 7/MC  7200 55 40 5 8200 58 38 4 4 12 3 10 11.2 11.4 N N N N N N 
30  1621 Divya 5/FC  6600 46 46 8 7300 51 45 5 3 12 5 14 12.3 12 N N N N N N 
31  5121 Simna 5/FC  8500 56 39 5 9100 56 38 6 3 7 3 6 13.7 13.5 N N N N N N 
32  4864 Inthiradevi 6/FC  9700 48 45 7 7400 51 45 4 3 8 3 8 13.5 13 N N N N N N 
33  4802 Pramila 5/FC  10,000 46 45 9 6900 48 47 5 3 10 5 12 12.0 10 N N N N N N 
34  6623 Saravanan 6/MC  11400 63 31 6 6300 66 32 2 22 38 3 5 13.5 13.3 N N N N N N 
35  6765 Kumar 4/MC  9600 64 30 6 7200 68 29 3 2 5 12 18 13.4 13.6 N N N N N N 
36  6869 Ansarali 6.5/MC 7900 47 46 7 6600 51 46 3 3 10 6 10 13.2 13 N N N N N N 
37  6860 Jhoncy 3/FC  6600 64 30 6 7700 67 30 3 5 15 7 14 10.4 10.8 N N N N N N 
38  3047 Hariswaran 4/MC  7400 57 35 8 7000 62 34 4 16 26 15 32 14 14.1 N N N N N N 
39  8035 Arun 6/MC  7800 62 32 6 8400 60 35 5 12 25 12 25 10 10.3 N N N N N N 
40    7833 Shanthi 4/FC  11,500 65 30 5 7100 62 35 3 13 26 10 40 9.1 9.6 N N N N N N 
BT – Before Treatment, AT – After Treatment, N - Nil.TC – Total Blood Count, DC – Differential Blood Count, P – Polymorphs, L – Leucocytes, E – Eosinophils 
3ESR – Erythrocytes Sedimentation Rate, mm – Milli meter Hb – Hemoglobin, Alb – Albumin, Sug – Sugar, Dep – Deposits,  
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CASE SUMMARY OF THE PATIENTS 
(Internal medicine) 
 
 
   
SL  
No  
OP : No          Name  Age / Sex  Result  
1      9542 Vishali 3/FC  Good  
2      9541  Vishvanathan 4/MC Good 
3      9963 Rumarleeka  3 1/2/FC  Good  
4      8268 Vikneshvaran 7/MC  Mild 
5     2143 Francy 7/FC  Good  
6     2273 Sanjay kumar 3/MC  Moderate 
7    4309 Mohana 5/FC  Mild  
8  5028 Janani  7/FC  Good  
9  6205 Yugalakshmi 6/FC  Good  
10  6081 Chinidini 6 1/2FC       Moderate 
11  7470 Jeevanandan 7/MC    Good  
12  7478 Dayalan 4/MC  Good  
13  7405 Seetha 4/FC         Mild 
14  7187 Dhiviyasri 3/FC     Moderate  
15  3634 Nithishraj 4/MC  Mild 
16  5903  Sandiya 7/FC Good 
17  6601 Jeevika 7/FC  Mild  
18  5057 Karthik 4/MC  Good 
19  9619  Thaniyala 3/FC  Good 
20       8196  Dinesh 7/MC       Moderate 
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                               CASE SUMMARY OF THE PATIENTS 
                                              (Internal&External) 
 
 
Sl  
No  
OP  No  Name  Age / Sex  Result  
21  5202 Asmitha 4/FC    Moderate 
22  6133 Srija 7/FC  Good  
23  6741 Sachin 7/MC  Mild 
24  6989 Dharun 4/MC  Moderate  
25  129 Mageshwari 7/FC  Mild 
26  959 Kirthika 5/FC    Moderate  
27  4643 Sathana 5/FC  Good  
28  5812  Charumathi 7/FC  Good  
29  5975 Dhanush 7/MC  Good  
30  1621 Divya 5/FC  Good 
31  5121 Simna 5/FC  Good  
32  4864 Inthiradevi 6/FC  Good  
33  4802 Pramila 5/FC  Good  
34  6623 Saravanan 6/MC  Moderate  
35   6765 Kumar 4/MC  Good  
36  6869 Ansarali 61/2/MC  Moderate 
37  6860 Jhoncy 3/FC  Good  
38  3047 Hariswaran 4/MC  Good 
39  8035 Arun 6/MC  Good  
40  7833 Shanthi 4/FC  Good  
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PATIENTS PHOTOS 
Name: Rumarleeka 
Age/Sex: 3½  / FC 
OP. No.: 9963 
BEFORE TREATMENT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name: Rumarleeka 
Age/Sex: 3½  / FC 
OP. No.: 9963 
AFTER TREATMENT 
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DISCUSSION 
 
Sirangu is the one of most common skin disease in paediatric age group. This 
disease mostly resembles scabies in modern system. Symptoms of Sirangu Nocturnal 
itching, Burrows, Pruritis papules, Pustules, Papulo vesicules.In this study 40 cases are 
treated in OPD of postgraduate department of Kuzhanthai Maruthuvam in Govt. Siddha 
Medical College, attached to Arignar Anna Hospital of Indian Medicine, Chennai-
106,from 2015-2017   
The patients were examined on siddha system of diagnosis with help of modern 
investigations. The patients are treated with the trial drug Oma Legium (Internal) and 
MusuttaiEnai(External) for 21days.  
 The observations are described here.  
1. Sex Distribution: 
Among the 40 cases 23 patients were female children and 17 patients were male 
children.Mostly female children affected. 
2. Age Distribution:  
Among the 40 cases, maximum numbers of patients 52.5% were in the age group 
of 3 to 5 years, 47.5% were in the age group of 6 to 7 years. 
3. Socio Economic status  
Among the 40 cases, maximum numbers of patients 70% were in poor status,  
30% were in middle class. The highest incidence was observed in poor class children due 
to poor hygienic, so the poor children are more prone to the disease.  
4. Family History  
Among the 40 cases, 65% of the patients showed negative family history, 35% 
patients showed positive family history. 
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5. Aetiological factors 
Among the 40 cases, 45% of the patients showed contact infected person, 37.5% 
of the patients showed poor hygiene and 17.5% of the patients showed poverty. 
6. Dietary Habits  
Among the 40 cases, 90% of the cases were mixed diet. 10% of cases were 
vegetarians. 
7. According to Paruvakalam  
Among the 40 cases, highest incidence 25% cases were observed in 
Koothirkalam,20%Muthuvenilkaalam,15% of cases in MunpaniKaalam and 
PinpaniKaalam12.5% of cases in KaarKaalam and ElavenilKaalam . 
8. Distribution of Thinai  
 Out of 40 cases, highest incidence 70% of cases were from in Neithal thinai and 
30% cases were in Kurinji thinai, as per siddha literature Vatham was predominant in 
neithal nilam so it may aggravate the skin diseases.  
9. Uyir Thathukkal  
Vatham  
Among the 40% cases,Viyanan and Samanan was affected 100%,Abanan was 
affected in 27.5% of patients, Kirukaran was affected in 20% of patients and Devathathan 
was affected in 7.5% of patients, 
Pitham 
Among the 40% cases,Prasakam was affected 100%. Anarpitham and 
Ranjagamwas affected in 20% of the patients. Prasakam is responsible for complexion of 
the skin so it was affected in all cases.  
Kabam 
Out of 40 cases, Kilethagam was affected 20% of the patients. 
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10. Ezhu Udal Kattugal  
Out of 40 patients Saram, Senneer and Oon was affected in all cases.  
11. Ennvagai Thervugal  
Out of 40 patients,Niram and Sparisam were affected in all the cases, Malam 
affected in 30% of the patients and Naa affected in 20% of cases. In this study 60% of 
patients have VathaPithaNaadi and 40% patients have PithaVathaNaadi.  
12. Neikuri 
Among the 40 cases,55% of patients were having Vatha neer, 30% of patients 
were having Kaba neer and 15% of patients were having Pitha neer.  
13. Clinical Features 
Among the 40 patients. 100% of cases have Nocturnal itching and Burrows. 75% 
of cases have Pruritis papules, 67.5% of cases have pustules, and 42.5% of the cases 
have Papulo vesicles. After treatment 7.5% of cases have Nocturnal itching and Pruritic 
papules, 5% of cases have Burrows, 
Routine examination of blood and urine were done before and after treatment. In 
most of the cases (80%) were having elevated ESR and increased eosinophil count and it 
has decreased after treatment. 
15. Phytochemical analysis 
         The Phytochemical analysis of the trial drug shows that the drug contains 
Chloride.Phosphate,iron,Alkaloides,Flavonoides,Glycosides,Carbohydrates,Triterpnoids,c
oumarins,Phenols,Tanin,Saponins,Proteins,Betacyanin. 
     Qualitative analysis of the Musuttai Ennai presence of  Alkaloids. 
16. Toxicity study of the drug:  
 The Acute and Sub-acute toxicity of the trial drug was carried out in Wistar 
albino rats reveals that the drug has no adverse effects, so it is safe to human beings. 
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 17. Physicochemical analysis:  
 Loss of Drying at 105 °C (%) - 39.43 ± 1.98 
Total Ash (%)5                       - 66  ± 1.69 
 PH                                           - 6          
Total Reducing sugar (%w/v)  - 22.76 ± 1.09 
 Total fat content  (%w/v)          - 6.75 ± 1.14  
 shows the safe and effectiveness of the drug Oma Legium. 
18. Pharmacological analysis:  
Pharmacological analysis showed the internal drug has significant anti-
inflammatory, anti-allergic, immune modulatory activity ,Anti microbial activity 
19. Statistical Analysis  
The preclinical studies of trial medicine statistically analysed and showed 
significant result.  
20. Results 
Among the 40 patient‟s good improvement observed in 26 cases (65%), moderate 
improvement in 7cases (17.5%) and mild improvement in 7cases (17.5%) and no adverse 
events observed clinically during the course of treatment.  
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SUMMARY 
To study the efficacy of siddha medicine OMA  LEGIUM(Internal medicine) 
and MUSUTTAI ENNAI(External medicine) in the treatment of Sirangu.This disease 
mostly resembles scabies in modern system. Literature evidences of both Siddha and 
Modern system were collected and also the ingredients of the trial drug was reviewed as 
well. 
For the clinical study 40 patients were selected based on Inclusion and Exclusion 
criteria. The study is conducted after the drug being screened by the Screening committee 
and the trial is also approved by the Institutional Ethical Committee (IEC).  
Animal studies are carried out after obtaining proper permission from the 
Institutional Animal Ethical Committee (IAEC). Forty children with SIRANGU 
diagnosed clinically treated in outpatient of Arignar Anna Hospital of Indian Medicine, 
Chennai-106.  They were observed for clinical improvement, laboratory investigation 
done and treated with trial drug.  
Pharmacological analysis showed the internal drug has significant anti-inflammatory, 
anti-allergic, immune modulatory activity ,Anti microbial activity to improve the Patients 
quality. 
Qualitative analysis of the Oma Legium presence of Chloride,Phosphate ,ferrous 
iron etc. Musuttai Ennai  presence of   Alkaloids. 
Physico chemical analysis of the trail drug shows the 
                           Loss of Drying at 105 °C (%)-39.43 ± 1.98 
                          Total Ash (% )5.66  ± 1.69 
                           PH - 6   
                           Total Reducing sugar (%w/v) - 22.76 ± 1.09 
,                         Total fat content  (%w/v) - 6.75 ± 1.14   
All the patients were kept under strict dietary control during the treatment. The 
observation on effect of therapy was encouraging.  
The external application gave soothing effect and also moistering the skin. 
Among the 40 patient‟s good improvement observed in 26 cases (65%), moderate 
improvement in 7 cases (17.5%) and mild improvement in 7 cases (17.5%) and 
Observation made during the clinical study showed that the trial drug was clinically 
effective and no adverse effect.   
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CONCLUSION 
Sirangu is one of most common skin disease in paediatric age group and mainly 
caused by kirumi, excessive heat of the body the blood is altered to produce Sirangu. 
In this clinical study OMA LEGIUM and MUSUTTAI ENNAI were taken as 
Internal & External medicine respectively. In OMA LEGIUM most of ingredients have 
Kaippu Suvai, it derangement of mainly Pitham following Vatham and decrease the heat. 
Toxicological studies showed no acute and sub-acute toxicity,Pharmacological 
analysis showed the internal drug has significant anti-inflammatory, anti-allergic, immune 
modulatory activity ,Anti microbial activity .In Bio chemical analysis iron present it 
effective for anaemia. 
The drug is easily administrable and cost effective. During the clinical study no adverse 
events were observed.  
 Statistically it is concluded that the treatment was effective and significant.  
Clinical results were found to be significant good improvement was found in 65% 
of cases, moderate in 17.5% of cases and mild in 17.5% of cases. The Clinical trial 
conducted in selected patients was satisfactory and encouraging. The trial medicine is 
effective for Sirangu in children. 
Through this study the effectiveness of trail drug is conformed and re established 
by the author. 
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BIO-CHEMICAL ANALYSIS 
PREPARATION OF EXTRACT: 
2 gm of the Musuttai Ennai is taken in a 100 ml beaker and 20 ml of distilled 
water is added. The solution is boiled for 10 minutes, cooled and then filtered. The filtrate 
is called extract. This fluid is taken for the Bio- Chemical analysis 
QUALITATIVE ANALYSIS 
 
S.NO 
 
EXPERIMENT 
 
OBSERVATION 
 
 
INFERENCE 
 I. TEST FOR ACID RADICALS   
1.  Test for Chloride 
2 ml of extract is added with dilute 
nitric acid till the effervescence ceases. 
Then 2 ml of silver nitrate solution is 
added 
Absence of white 
precipitate 
Absent 
2.  Test for Phosphate: 
2 ml of the extract is treated with 2ml of 
Ammonium molybdate solution and 2 
ml of concentrated nitric acid 
Absence of yellow 
precipitate 
Absent 
3.  Test for Carbonate: 
 2 ml of the extract is treated with 2 ml 
of magnesium sulphate solution  
Absence of white 
precipitate 
Absent 
4.  Test for Sulphide: 
1 gm of the substance is treated with 2 
ml of concentrated Hydrochloric acid 
Absence of Rotten 
egg smelling 
Absent 
5.  Test for Sulphate: 
2ml of the above prepared extract is 
taken in a test tube to this added 2ml of 
4% ammonium oxalate solution 
Absence of White 
precipitate 
Absent 
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6.  Test for Nitrate 
1 gm of the substance is heated with 
copper turnings and concentrated 
sulphuric acid and viewed the test tube 
vertically down 
Absence of 
Reddish brown gas 
Absent 
7.  Test for Nitrite 
 3 drops of the extract is placed on a 
filter paper. On that, 2 drop of Acetic 
acid and 2 drops of Benzidine solution 
is placed 
Absence of 
yellowish red 
colour 
Absent 
8.  Test for Borate 
2 pinches of the substance is made into 
paste by using Sulphuric acid and 
Alcohol (95%) and introduced into the 
blue flame 
Absence of Green 
tinged flame 
Absent 
 
  II 
 
TEST FOR BASIC RADICALS 
  
9.  Test for copper 
 One pinch of the substance is made into 
paste with concentrated Hydrochloric 
acid in a watch glass and introduced 
into the Non luminous part of the flame 
Absence of Bluish 
green coloured 
flame 
Absent 
10.  Test for  iron 
 To the 2 ml of extract, 2 ml of 
Ammonium thiocyanate solution is 
added. 
Absence of blood 
red colour 
Absent 
11.  Test for zinc 
To the 2 ml of extract Sodium 
hydroxide solution is added in drops to 
excess 
Absence of white 
precipitate 
Absent 
12.  Test for calcium 
2 ml of the extract is added with 2 ml of 
4 % Ammonium oxalate solution.  
Absence  of white 
precipitate 
Absent 
13.  Test for magnesium  
2ml of extract sodium hydroxide 
solution is added in drops to excess 
Absence of white 
precipitate 
Absent 
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14.  Test for potassium 
A pinch of  substance is treated with 2 
ml of sodium nitrite solution and then 
treated with 2 ml of Cobalt nitrate in 
30% glacial Acetic acid 
Absence of yellow 
precipitate 
Absent 
15.  Test for sodium 
2 pinches of the substance is made into 
paste by using Hydrochloric acid and 
introduced into the blue flame 
Absence of yellow 
colour flame 
Absent 
16.  Test for starch  
 2 ml of extract is treated with weak 
iodine solution  
Absence of blue 
colour  
Absent 
17.  Test for reducing sugar 
 5 ml of Benedict‟s qualitative solution 
is taken in a test tube and allowed to 
boil for 2 minutes and added 10 drops 
of the extract and again boiled for 2 
minutes. The colour changes are noted 
Absence of Green 
colour 
Absent 
18.  Test for tannic acid 
The extract is treated with ferric 
chloride solution 
Presence  of Blue 
black precipitate  
Absent 
19.  Test of the alkaloids 
2 ml of the extract is treated with 2 ml 
of  Picric acid 
Trace yellow 
colour developed 
Present 
 
RESULTS: 
The trial drug Musuttai Ennai contains 
Basic radicals:  
Alkaloids. 
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II.BIO-CHEMICAL ANALYSIS 
PREPARATION OF EXTRACT: 
2 gm of the OmaLegiumis taken in a 100 ml beaker and 20 ml of distilled water is added. 
The solution is boiled for 10 minutes, cooled and then filtered. The filtrate is called 
extract. This fluid is taken for the Bio- Chemical analysis 
QUALITATIVE ANALYSIS 
S.NO EXPERIMENT OBSERVATION INFERENCE 
 I. TEST FOR ACID RADICALS   
1.  Test for Chloride 
2 ml of extract is added with dilute 
nitric acid till the effervescence ceases. 
Then 2 ml of silver nitrate solution is 
added 
 white precipitate 
is formed 
Present 
2.  Test for Phosphate: 
2 ml of the extract is treated with 2ml of 
Ammonium molybdate solution and 2 
ml of concentrated nitric acid 
 yellow precipitate 
is formed 
Present 
3.  Test for Carbonate: 
 2 ml of the extract is treated with 2 ml 
of magnesium sulphate solution  
Absence of white 
precipitate 
Absent 
4.  Test for Sulphide: 
1 gm of the substance is treated with 2 
ml of concentrated Hydrochloric acid 
Absence of Rotten 
egg smelling 
Absent 
5.  Test for Sulphate: 
2ml of the above prepared extract is 
taken in a test tube to this added 2ml of 
4% ammonium oxalate solution 
Absence white 
precipitate  
Absent 
6.  Test for Nitrate 
1 gm of the substance is heated with 
copper turnings and concentrated 
sulphuric acid and viewed the test tube 
vertically down 
Reddish brown gas 
is evolved 
Absent 
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7.  Test for Nitrite 
 3 drops of the extract is placed on a 
filter paper. On that, 2 drop of Acetic 
acid and 2 drops of Benzidine solution 
is placed 
Absence of 
yellowish red 
colour 
Absent 
8.  Test for Borate 
2 pinches of the substance is made into 
paste by using Sulphuric acid and 
Alcohol (95%) and introduced into the 
blue flame 
Absence of Green 
tinged flame 
Absent 
  II TEST FOR BASIC RADICALS   
9.  Test for copper 
 One pinch of the substance is made into 
paste with concentrated Hydrochloric 
acid in a watch glass and introduced into 
the Non luminous part of the flame 
Absence of Bluish 
green coloured 
flame 
Absent 
10.  Test for iron 
 To the 2 ml of extract, 2 ml of 
Ammonium thiocyanate solution is 
added. 
Presence of blood 
red colour 
Present 
11.  Test for zinc 
To the 2 ml of extract Sodium 
hydroxide solution is added in drops to 
excess 
Absence of white 
precipitate 
Absent 
12.  Test for calcium 
2 ml of the extract is added with 2 ml of 
4 % Ammonium oxalate solution.  
Presence of white 
precipitate 
Absent 
13.  Test for magnesium  
2ml of extract sodium hydroxide 
solution is added in drops to excess 
Absence of white 
precipitate 
Absent 
14.  Test for potassium 
A pinch of  substance is treated with 2 
ml of sodium nitrite solution and then 
treated with 2 ml of Cobalt nitrate in 
30% glacial Acetic acid 
Absence of yellow 
precipitate 
Absent 
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15.  Test for sodium 
2 pinches of the substance is made into 
paste by using Hydrochloric acid and 
introduced into the blue flame 
Absence of yellow 
colour flame 
Absent 
16.  Test for starch  
 2 ml of extract is treated with weak 
iodine solution  
Absence of blue 
colour  
Absent 
17.  Test for reducing sugar 
 5 ml of Benedict‟s qualitative solution 
is taken in a test tube and allowed to 
boil for 2 minutes and added 10 drops of 
the extract and again boiled for 2 
minutes. The colour changes are noted 
Absence of Green 
colour 
Absent 
18.  Test for tannic acid 
The extract is treated with ferric 
chloride solution 
Absence of Blue 
black precipitate  
Absent 
19.  Test of the alkaloids 
2 ml of the extract is treated with 2 ml 
of  Picric acid 
Trace yellow 
colour developed 
Absent 
 
RESULTS: 
The trial drug OmaLegium contains  
Acid radical: 
Chloride. Phosphate. 
Basic radicals:  
Iron. 
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ICP-MS- Heavy Metal Analysis 
ICP-MS- Heavy Metal Analysis Report 
ICP-MS 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS): ICP-MS is a type of 
mass spectrometry that is highly sensitive and capable of the determination of a range of 
metals and several non-metals at concentration below one part in 1012 (parts per trillion). 
Samples are decomposed to neutral elements in high temperature argon plasma and 
analyzed based on their mass to charge ratios. It is an automated, simple and unique 
quantitative and qualitative analysis. It measures elemental isotopes ratio. 
Procedure 
Digestion of sample is carried out by transforming 2.5 ml of the sample into a 
closed beaker and 5 ml of concentrated HNO3 was added and digested to near dryness. 16 
M nitric acid was further added each time to the sample and digested until the clear 
solution was obtained. 5ml of 12 M Hydrochloric acid was added to ensure complete 
digestion .The digested solution was cooled to room temperature and made to the final 
volume of 100 ml with deionized water. Sample solutions were then filtered through 
membrane (0.45micron) filter. Finally, the digested samples were used for metal analysis 
using inductively coupled plasma Mass Spectrometry (Perkin Elmer DRC-e Model) .Each 
sample was digested in triplicate. A blank solution was also prepared in a similar manner. 
Machine Model: Agilent 7700 ICPMS 
Sample ID: OL 
Element Concentration (mg/L) Upper Limit (mg/L) 
Cadmium (Cd) BDL 
 
0.299 
 BDL- Below Detective Level 
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PHYTOCHEMICAL ANALYSIS 
Sample Preparation 
Oma Legium  (OL) was extracted with hydro alcoholic solvent (Methanol: water) 
6:4 and the extract was subjected to the following analysis 
Test for alkaloids: 
Mayer's Test: To the extract, 2ml of mayer's reagent was added, a dull white 
precipitate revealed the presence of alkaloids. 
 
1) Test for coumarins:  
       To 1 ml of extract, 1 ml of 10% sodium hydroxide was added. The presence of 
coumarins is indicated by the formation of yellow color. 
2) Test for saponins:  
       To 1 ml of the extract, 5 ml of water was added and the tube was shaken vigorously. 
Copious lather formation indicates the presence of Saponins. 
3) Test for tannins:  
       To the extract, ferric chloride was added, formation of a dark blue or greenish black 
color showed the presence of tannins. 
4) Test for glycosides- Borntrager’s Test 
Test drug is hydrolysed with concentrated hydrochloric acid for 2 hours on a water 
bath, filtered and the hydrolysate is subjected to the following tests. To 2 ml of filtered 
hydrolysate, 3 ml of choloroform is added and shaken, choloroform layer is separated and 
10% ammomia solution is added to it. Pink colour indicates presence of glycosides. 
5) Test for flavonoids: 
To 0.1ml of the test sample about 5 ml of dilute ammonia solution were been 
added followed by addition of few drops of conc. Sulfuric acid. Appearance of yellow 
color indicates the presence of Flavonoids. 
6) Test for phenols: 
Lead acetate test: The extract was taken; 3 ml of 10% lead acetate solution was 
added.  A bulky white precipitate indicated the presence of phenolic compounds. 
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7) Test for cardial glycosides:Keller-Killani Test:  
  Plant extract treated with 2 ml glacial acetic acid containing a drop of         FeCl3 
.A brown colour ring indicates the presence of positive test. 
8) Test for steroids: 
To the test solution 2ml of chloroform was added with few drops of conc. 
Sulphuric acid (3ml), and shaken well. The upper layer in the test tube was turns into red 
and sulphuric acid layer showed yellow with green fluorescence. It showed the presence 
of steroids. 
9) Test for Quinones:  
The extracts were treated separately with Alc. KOH solution. Appearance of 
colors ranging from red to blue indicates the presence of Quinones. 
 
10) Test for Cyanins 
A. Aanthocyanin: 
       To 2 ml of the leaf extract, 1 ml of 2N sodium hydroxide was added and heated for 5 
min at 100 Cᵒ. Formation of bluish green colour indicates the presence of anthocyanin. 
B. Betacyanin: 
To 2 ml of the leaf extract, 1 ml of 2N sodium hydroxide was added and heated for 5 
min at 100 Cᵒ.  Formation of yellow colour indicates the presence of betacyanin. 
11) Test for Carbohydrates - Benedict’s test 
To 0.5 ml of test drug about 0.5 ml of Benedic‟s reagent is added. The mixture is 
heated on a boiling water bath for 2 minutes. A characteristic coloured precipitate 
indicates the presence of sugar. 
12) Test for terpenoids: 
Salkowski test: 5ml of extract was mixed in 2ml of chloroform, and concentrated 
sulphuric acid was carefully added to form a layer.  A reddish brown colouration of the 
interface indicates the presence of terpenoids. 
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RESULTS 
 
Test for Alkaloids          Test for Coumarins          Test for Saponins 
                                            
 
 
 
 
Test for Tanins                    Test for Glycosides         Test for Flavonoids 
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Test for Phenols           Test for Cardiac Glycosides                 Test for Steroids 
        
                                   
 
 
      Test for Terpenoids                 Test for Quinones                      Test for Protein 
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       Test for Anthocyanins                                          Test for Carbohydrates 
             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                      Result Analysis 
 
PHYTOCOMPONENTS OL 
ALKALOIDS + 
FLAVONOIDS + 
GLYCOSIDES + 
STEROIDS - 
CARBOHYDRATES + 
TRITEREPNOIDS + 
COUMARINS + 
PHENOLS + 
CARDIAC GLYCOSIDES - 
TANNINS + 
SAPONINS + 
PROTEINS + 
ANTHOCYANIN - 
BETACYANIN + 
QUINONES - 
 
+   Indicates positive,  - Indicates Negative. 
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PHYSICOCHEMICAL ANALYSIS 
Project ID  : NRS/AS/0019/01/2017  
Institute  : Govt Siddha Medical College  
Sample Name  : Oma Legium 
Sample ID   : OL  
Percentage Loss on Drying 
10gm of test drug was accurately weighed in evaporating dish .The sample was 
dried at 105
o
C for 5 hours and then weighed. 
Percentage loss in drying = Loss of weight of sample/ Wt of the sample X 100 
Determination of Total Ash 
3 g of test drug was accurately weighed in silica dish and incinerated at the 
furnace a temperature 400 ºC until it turns white in color which indicates absence of 
carbon. Percentage of total ash will be calculated with reference to the weight of air-dried 
drug. 
Total Ash = Weight of Ash/Wt of the Crude drug taken X 100 
Determination of PH 
About 5 g of test sample will be dissolved in 25ml of distilled water and filtered 
the resultant solution is allowed to stand for 30 mins and the subjected to pH evaluation  
Determination of Total Reducing Sugar Content 
20gm wt. equivalent to 20ml of the sample was taken and to which 10ml of conc 
HCl were added and kept it aside for overnight. Neutralize this solution with 
approximately 1M NaOH add  10 ml of 21.9 g zinc acetate, 3ml glacial acetic acid 
followed by 10.6 g potassium ferrocyanide and distilled water was added to make a 
volume of 100ml. 10ml of Fehling solution was taken and burette solution was added 
drop wise and heat to boiling over hot plate till blue color appeared. At this time, two 
drops of methylene blue was added and the titration was carried on till brick red color was 
obtained 
Mg of sugar in 100 ml = Total reducing sugar x 100 / Titer value 
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Determination of total fat content 
Weigh 4gms of sample in the thimble and place it in soxhlet fitted condenser. 
Take 100 ml of petroleum ether in round bottom flask and boil for 4 hours. Take the 
extract in pre weighed conical flask and evaporate the petroleum ether on water bath. 
Remove trace of pet ether with vacuum pump. Take the weight of the residue to constant 
fat weight. 
 
 
S.No Parameter Mean (n=3) SD 
1.  Loss on Drying at 105 °C (%) 39.43 ± 1.98 
2.  Total Ash (%)  5.66  ± 1.69 
3.  Total Reducing sugar  (%w/v) 22.76 ± 1.09 
4.  Total fat content  (%w/v) 6.75 ± 1.14 
5.  pH  6 
Final Test report 
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STERILITY TEST BY POUR PLATE METHOD 
Objective  
The pour plate techniques were adopted to determine the sterility of the product. 
Contaminated / un sterile sample (formulation) when come in contact with the nutrition 
rich medium it promotes the growth of the organism and after stipulated period of 
incubation the growth of the organism was identified by characteristic pattern of colonies. 
The colonies are referred to as Colony Forming Units (CFUs).   
Methodology 
About 1ml of the test sample was inoculated in sterile petri dish to which about 15 
mL of molten agar 45
o
C were added. Agar and sample were mixed thoroughly by tilting 
and swirling the dish. Agar was allowed to completely gel without disturbing it. (about 10 
minutes). Plates were then inverted and incubated at 37
o
 C for 24-48 hours. Grown 
colonies of organism was then counted and calculated for CFU.  
 
 
 
 
 
 
 
 
Observation 
No growth was observed after incubation period. Reveals the absence of specific 
pathogen 
 
Result 
 
No growth / colonies were observed in any of the plates inoculates with the test 
sample. 
 
Test Specification Result Method 
E-coli Absent Absent 
As per AYUSH specification 
Salmonella Absent Absent 
Staphylococcus Aureus Absent Absent 
Pseudomonas Aeruginosa Absent Absent 
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Project Report on Toxicity Profiling of Oma Legium 
Name Dr. M.SUMATHI 
IAEC SU/CLATR/IAEC/VII/041/2016 
Name of the 
Formulation 
Oma Legium 
Abbreviation 
OL 
 
                                                 ACUTE TOXICITY STUDY 
Acute toxicity study of the study drug Oma Legium was carried out as per OECD 
guideline (Organization for Economic Co-operation and Development) Guideline-423. 
Animal 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well ventilated 
with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle were maintained 
.Room temperature was maintained between 22 + 2
0 
C
 
and relative humidity 50–65%. 
They were provided with food (Sai feeds, Bangalore, India) and water ad libitum. All the 
animals were acclimatized to the laboratory for 7 days prior to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
Acute toxicity Study 
Acute toxicity study will be carried out in accordance with OECD guideline 423 
1
. 
The animals were fasted overnight with free access to water. The study was conducted 
with single oral dose administration of Oma Legium.  
IAEC SU/CLATR/IAEC/VII/041/2016 
Animal Grouping 
One group consist of 6 female rats were used for this study. The dose utilized for 
evaluation of acute toxicity study is about 2000 mg/kg higher than that of the therapeutic 
dose.  
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Animal Grouping 
GROUP I : Animals received Test drug 2000 mg/kg (p.o)  
The animals were fasted overnight (12- 16 hrs) with free access to water. The 
study was conducted with single oral administration of study drug Oma Legium 
2000mg/kg (p.o). The animals were observed continuously for first 72 h and then 14 days 
for emerging signs of behavioral changes, body weight changes and for mortality. 
Occurrence of toxicity in animals were observed continuously for the first 4 to 24 
h and observed periodically for the next 14 days.  Observation includes the change in 
skin, fur, eyes and mucus membrane. Appearance of C.N.S,C.V.S and A.N.S related 
toxicity such as tremors, convulsions, sedation, steric behavior, respiratory distress, 
cardiovascular collapse, response to sensory stimuli, salivation, diarrhea, lethargy, sleep, 
coma and mortality were observed with special attention.   
Body weight was recorded periodically. At the end of the experiment all animals 
were subjected for gross necropsy and observed for pathological changes. 
SUB-ACUTE TOXICITY STUDY 
Sub-acute toxicity study was carried out as per OECD guidelines Guideline-407. 
Animals 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well ventilated 
with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle were maintained 
.Room temperature was maintained between 22 + 2
o 
C
 
and relative humidity 50–65%. 
They were provided with food (Sai feeds, Bangalore, India) and water ad libitum. All the 
animals were acclimatized to the laboratory for 7 days prior to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
IAEC SU/CLATR/IAEC/VII/041/2016 
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Animal Grouping 
Animals were divided into three groups of 06 animals each consist of 3 male and 3 
female rats. 
GROUP I : Animals received saline 5 ml/kg b.w (p.o)             
GROUP II : Animals received low dose of test drug 200 mg/kg (p.o) 
GROUP III : Animals received high dose of test drug 400 mg/kg (p.o) 
The animals were randomly divided into control group and drug treated groups for 
two different doses viz. low dose (200 mg/kg b.w) and high dose (400 mg/kg b.w). 
The animals were administrated with the study drug once daily for 28 days. The 
animals in group I (control group) received normal saline 5 ml/kg b.w. The animals in 
group II received low dose of Oma Legium 200 mg/kg b.w (p.o) and group III received 
high dose of Oma Legium 400 mg/kg b.w (p.o). 
The rats were weighed periodically and observed for signs of toxicity pertains to 
C.N.S, C.V.S, A.N.S including behavioral changes, food - water intake and morphological 
changes. At the end of 28
th
 day, the animals were fasted for overnight with free access to 
water. On 29
th
 day the animals were sacrificed with excess anesthesia. Blood samples 
were collected from aorta and stored in EDTA (ethylenediamine –tetra actate) for 
Hematological analysis and for serum generation for biochemical analysis. 
The vital organs including heart, brain, lungs, spleen, kidneys, liver, stomach, 
testes, and ovary were harvested and carefully examined for gross lesions. The organs 
were preserved in 10% formalin for histopathological assessment and interpretation. 
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Hematological analysis 
Blood samples were analyzed using established procedures and automated Bayer 
Hematology analyzer. Parameters evaluated include Packed Cell Volume (PCV), Red 
Blood Cells (RBC) count, White blood cell count (WBC), Platelet Count, Hemoglobin 
(Hb), Mean cell Haemoglobin Concentration (MCHC), Mean Red Cell Volume (MCV), 
Mean Cell Hemoglobin (MCH), Mean platelet volume (MPV), Neutrophils, Eosinophil‟s, 
Basophils, Lymphocytes and Monocytes.  
Biochemical analysis 
3
 
Serum samples were analyzed for High Density Lipoprotein (HDL), Low density 
Lipoprotein (LDL) , Very low density Lipoprotein (VLDL) , Triglycerides (TGL), Total 
Cholesterol , Blood urea nitrogen (BUN), Creatinine, Albumin, Total Protein, Glucose, 
Uric acid, Aspartate Transaminase (AST), Alanine amino Transaminase (ALT) and 
Alkaline  Phosphatase (ALP) using Mind ray auto analyzer model BS 120. 
Histopathological evaluation 
4
 
 Organs included of heart, brain, lungs, spleen, kidneys, liver, stomach, testes and 
ovary. Histological slides of organs were made and observed under the microscope.  The 
pathological observations of cross section of these organs were performed on gross and 
microscopic bases. Histological examinations were performed on the preserved tissues 
with particular emphasis on those which showed gross pathological changes. 
Statistical analysis 
The statistical analysis was carried by one way ANOVA (GRAPH PAD PRISM 5 
computer program). Results were expressed as mean ± standard error .A statistical 
comparison was carried out using the Dunnet‟s test for the control and treatment group.  
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Fecal Pellet Analysis 
Methodology 
 
Rats of control and treatment group were allowed to explore to open field on clean and 
sterile Stainless steel tray. The collected pellets were analyzed for consistency, color, 
Shape, Presence of blood cells etc 
 
       
 
Muscle Grip Strength Analysis:The grip strength test is a simple non-invasive method 
designed to evaluate rat muscle force in vivo. Rats of control and drug treated group was allowed 
to hold the pull bar with both the hind limbs firmly then the animal was gently pulled back with 
the tail until the animal lost the grip toward the bar. The procedure was repeated to get the average 
value. Muscle grip ness of the drug treated group was compared to that of the control rat to ensure 
the change in coordination.  
Metabolic Cage for Urine Collection 
Rat of control and treatment group was placed individually in metabolic cage with free 
access to feed and water. Urine dropping from the animal was collected using specialized 
wire mesh system fixed at the base of the cage having provision to trap the fecal pellet 
mixed with urine sample. The collected urine sample was subjected to analysis with 
respect to colour, pH, glucose, ketone bodies, pus and blood cells. 
Acute Toxicity Study 
Analysis Group I 
Consistency Soft 
Shape Oblong 
Colour Dark Brown 
Mucous Shedding Absence 
Blood Cells Absent 
Signs 
 
of Infection 
None 
Observed 
Sub-Acute Toxicity Study 
Analysis Group I Group II Group III 
Consistency Soft Soft Soft 
Shape 
Oblong 
 
Oblong Rectangular 
Colour Greenish Greenish Greenish 
Mucous 
Shedding 
Absence Absence Absence 
Blood Cells Absent Absent Absent 
Signs of 
Infection 
None 
Observed 
None 
Observed 
None 
Observed 
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RESULTS 
Assessment of clinical signs in rats treated with Oma Legium on Acute toxicity study 
Acute 
Parameter Group I 
Clinical Signs Parameters for  
the duration of 14 days Test Drug 2000mg/kg 
Number of animals observed 6 Female  
Lacrimation Absence 
Salivation Absence 
Animal appearance Normal 
Tonic Movement Absence 
Clonic Movement Absence 
Laxative action Absence 
Touch Response Normal 
Response to Sound Normal Response 
Response to Light Normal Response 
Mobility Normal Response 
Respiratory Distress Nil 
Skin Color Normal 
Stereotype behavior Absence 
Piloerection Absence 
Limb Paralysis Absence 
Posture Normal 
Open field behavior Normal 
Giat Balancing Normal 
Freezing Behaviour Absent 
Sings of Stress and Anxiety None Observed 
Muscular coordination Normal 
Muscle grip Normal 
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Sedation Absence 
Social Behavior Normal 
Urine Analysis No Abnormality 
Urine Colour Yellowish 
Urine pH 6 
Urine -Glucose                         Absence 
Urine -Ketones                        Absence 
Urine- Bilirubin                         Absence 
Urine-Blood  Cells       Negative 
Urine - Pus cells Negative 
Mortality Nil 
 
Quantitative data on the body weight of rats treated with Oma Legium in Acute 
toxicity study 
Group I Before Treatment Weight in Gms After Treatment Weight in Gms 
Mean 180 191.8 
Std. Deviation 6.542 8.256 
Std. Error 2.671 3.371 
 
Values are mean ± S.D (n = 6 per group). Statistical significance carried out using 
one way ANOVA followed by Dunnett‟s test. 
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Assessment of clinical signs in rats treated with Oma Legium on Sub-Acute toxicity 
study 
SUB ACUTE 
Parameters Group I Group II Group III 
Clinical Signs Parameters for 
the duration of 28 days 
Control 
Test Drug 
200mg/kg 
Test Drug 
400mg/kg 
Number of animals observed 
3 Males and 
3Females  
3 Males and 
3Females  
3 Males and 
3Females  
Lacrimation Absence Absence Absence 
Salivation Absence Absence Absence 
Animal appearance Normal Normal Normal 
Tonic Movement Absence Absence Absence 
Clonic Movement Absence Absence Absence 
Laxative action Absence Absence Absence 
Touch Response Normal Normal Normal 
Response to Sound 
Normal 
Response 
Normal 
Response 
Normal 
Response 
Response to Light 
Normal 
Response 
Normal 
Response 
Normal 
Response 
Mobility 
Normal 
Response 
Normal 
Response 
Normal 
Response 
Respiratory Distress Nil Nil Nil 
Skin Color Normal Normal Normal 
Stereotype behavior Absence Absence Absence 
Piloerection Absence Absence Absence 
Limb Paralysis Absence Absence Absence 
Posture Normal Normal Normal 
Open field behavior Normal Normal Normal 
Giat Balancing Normal Normal Normal 
Freezing Behaviour Absent Absent Absent 
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Sings of Stress and Anxiety None Observed None Observed None Observed 
Muscular coordination Normal Normal Normal 
Muscle grip Normal Normal Normal 
Sedation Absence Absence Absence 
Social Behavior Normal Normal Normal 
Urine Analysis No Abnormality No Abnormality No Abnormality 
Urine Colour Yellowish Yellowish Yellowish 
Urine pH 6 7 7 
Urine -Glucose                         Absence Absence Absence 
Urine -Ketones                        Absence Absence Absence 
Urine- Bilirubin                         Absence Absence Absence 
Urine-Blood  Cells       Negative Negative Negative 
Urine - Pus cells Negative Negative Negative 
Mortality Nil Nil Nil 
 
  Effect of Oma Legium  on Body weight of Rats in Sub-acute toxicity study 
Group I Before Treatment Weight in Gms After Treatment Weight in Gms 
Mean 184 195.5 
Std. Deviation 5.177 5.958 
Std. Error 2.113 2.432 
Group II Before Treatment Weight in Gms After Treatment Weight in Gms 
Mean 176.7 189.5 
Std. Deviation 4.227 3.674 
Std. Error 1.726 1.5 
Group III Before Treatment After Treatment Weight in Gms 
Mean 183.8 194.5 
Std. Deviation 5.845 5.01 
Std. Error 2.386 2.045 
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Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett‟s test. 
Quantitative data on the food and water intake of rats treated with Oma Legium  for 
28 days in Sub-acute toxicity study 
GROUP I Food intake Water intake 
Mean 17.42 22.25 
Std. Deviation 3.573 6.437 
Std. Error 1.787 3.219 
GROUP II Food intake Water intake 
Mean 15 29.25 
Std. Deviation 2.126 1.524 
Std. Error 1.063 0.7622 
GROUP III Food intake Water intake 
Mean 16.5 22.58 
Std. Deviation 2.285 2.754 
Std. Error 1.143 1.377 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control 
and treatment groups were compared statistically using one way ANOVA followed by 
Dunnett‟s test. 
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Effect of Oma Legium on Haematology profile of rats in sub-acute toxicity study. 
GROUP I 
WBC 
count 
(×103 µl) 
RBC                  
(×10 
6
 µl) 
PLT                  
(×10 
3
 
µl) 
MCV                       
(fl) 
MCH             
(pg) 
MCHC          
(g/dl) 
HGB         
(g/dl) 
Mean 9.933 6.6 679.8 58.83 19.22 32.75 13.27 
Std. Deviation 1.483 1.103 174.3 6.218 2.232 1.299 1.089 
Std. Error 0.6053 0.4502 71.15 2.538 0.9112 0.5303 0.4447 
GROUP II 
WBC 
count 
(×103 µl) 
RBC                  
(×10 
6
 µl) 
PLT                  
(×10 
3
 
µl) 
MCV                       
(fl) 
MCH             
(pg) 
MCHC          
(g/dl) 
HGB         
(g/dl) 
Mean 10.98 6.867 824.5 64.52 19.55 31.53 13.33 
Std. Deviation 1.757 1.007 105.6 4.59 2.091 2.161 1.275 
Std. Error 0.7171 0.4112 43.1 1.874 0.8535 0.8823 0.5207 
GROUP III 
WBC 
count 
(×103 µl) 
RBC                  
(×10 
6
 µl) 
PLT                  
(×10 
3
 
µl) 
MCV                       
(fl) 
MCH             
(pg) 
MCHC          
(g/dl) 
HGB         
(g/dl) 
Mean 10.52 6.4 775.7 59.25 18.02 32.72 12.52 
Std. Deviation 1.775 1.304 154.4 5.377 2.576 1.412 0.9827 
Std. Error 0.7245 0.5323 63.03 2.195 1.052 0.5764 0.4012 
  
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control 
and treatment groups were compared statistically using one way ANOVA followed by 
Dunnett‟s test. 
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Effect of Oma Legium  on Haematology profile of rats in sub-acute toxicity study. 
GROUP I 
Lymph        
(%) 
Mon            
(%) 
Neutrophils   
10
3
/mm3 
Eosinophils 
(%) 
Basophils 
(%) 
MPV     
(fl) 
Mean 80.92 3.6 2.5 1.667 0.1667 5.833 
Std. Deviation 6.151 0.9033 0.6033 0.2251 0.4082 1.14 
Std. Error 2.511 0.3688 0.2463 0.09189 0.1667 0.4652 
GROUP II 
Lymph        
(%) 
Mon            
(%) 
Neutrophils   
10
3
/mm3 
Eosinophils 
(%) 
Basophils 
(%) 
MPV     
(fl) 
Mean 72.78 3.517 2.05 1.65 0.3333 5.733 
Std. Deviation 10.86 1.283 0.3146 0.2881 0.5164 0.8214 
Std. Error 4.433 0.5237 0.1285 0.1176 0.2108 0.3353 
GROUP III 
Lymph        
(%) 
Mon            
(%) 
Neutrophils   
10
3
/mm3 
Eosinophils 
(%) 
Basophils 
(%) 
MPV     
(fl) 
Mean 70.3 2.433 2.3 1.617 0 4.783 
Std. Deviation 3.422 0.871 0.502 0.2137 0 0.5776 
Std. Error 1.397 0.3556 0.2049 0.08724 0 0.2358 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control 
and treatment groups were compared statistically using one way ANOVA followed by 
Dunnett‟s test. 
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Effect of Oma Legium on Serum Bio-chemistry profile of rats in sub-acute toxicity 
study 
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Mean 77 18.83 0.6833 117 74.33 69.17 31.33 16.45 
Std. 
Deviation 
6.066 2.317 0.1722 4.942 5.888 3.545 5.007 2.971 
Std. Error 2.477 0.9458 0.07032 2.018 2.404 1.447 2.044 1.213 
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Mean 78.83 15.33 0.85 124.3 78.83 67.33 38 18.93 
Std. 
Deviation 
6.676 4.967 0.2258 11.01 10.38 5.279 9.899 1.484 
Std. Error 2.725 2.028 0.0922 4.495 4.238 2.155 4.041 0.6059 
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Mean 84.83 16.83 0.8 113.8 87.33 67.33 30.83 15.62 
Std. 
Deviation 
13.09 3.125 0.1789 8.477 16.08 5.046 6.911 3.421 
Std. Error 5.344 1.276 0.07303 3.461 6.566 2.06 2.822 1.397 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control 
and treatment groups were compared statistically using one way ANOVA followed by 
Dunnett‟s test. 
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Effect of Oma Legium on Serum Bio-chemistry profile of rats in sub-acute toxicity 
study 
GROUP I 
Serum total 
protein (g/dl) 
Serum 
albumin (g/dl) 
(AST)  
(IU/ml) 
(ALT)               
(IU/L) 
(ALP)         
(IU/L) 
Mean 6.35 3.6 102.3 36.5 112 
Std. Deviation 0.9995 0.08944 13.87 7.714 15.47 
Std. Error 0.408 0.03651 5.661 3.149 6.314 
GROUP II 
Serum total 
protein (g/dl) 
Serum 
albumin (g/dl) 
(AST)  
(IU/ml) 
(ALT)               
(IU/L) 
(ALP)         
(IU/L) 
Mean 5.767 3.933 109.5 22.17 137.8 
Std. Deviation 0.8914 0.5354 19.65 2.927 13.33 
Std. Error 0.3639 0.2186 8.024 1.195 5.443 
GROUP III 
Serum total 
protein (g/dl) 
Serum 
albumin (g/dl) 
(AST)  
(IU/ml) 
(ALT)               
(IU/L) 
(ALP)         
(IU/L) 
Mean 6.233 4.083 99.33 27.83 114.7 
Std. Deviation 0.9158 0.6646 10.21 4.875 26.47 
Std. Error 0.3739 0.2713 4.169 1.99 10.81 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control 
and treatment groups were compared statistically using one way ANOVA followed by 
Dunnett‟s test. 
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Quantitative data on absolute organ weight of rats treated with Oma Legium for 28 
days in Sub-acute toxicity study. 
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Mean 0.7683 5.948 1.617 0.5667 1.483 1.6 1.15 1.833 0.8667 
Std. Deviation 0.05636 0.9834 0.2137 0.1633 0.1472 0.3162 0.501 0.4933 0.4041 
Std. Error 0.02301 0.4015 0.08724 0.06667 0.06009 0.1291 0.2045 0.2848 0.2333 
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Mean 0.6517 5.103 1.667 0.6333 1.7 1.583 1.083 2.633 0.7333 
Std. Deviation 0.2142 0.669 0.1966 0.1506 0.2098 0.2994 0.4622 1.007 0.4933 
Std. Error 0.08746 0.2731 0.08028 0.06146 0.08563 0.1222 0.1887 0.5812 0.2848 
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Mean 0.755 5.862 1.733 0.6 1.533 1.55 1.033 3.167 0.8667 
Std. Deviation 0.1748 0.6814 0.1033 0.1549 0.1366 0.2168 0.2875 0.6658 0.3786 
Std. Error 0.07136 0.2782 0.04216 0.06325 0.05578 0.08851 0.1174 0.3844 0.2186 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females) for 
Heart, Liver, Kidney, Brain, Spleen, Lung, Stomach.   Values are mean ± S.D (n = 3 per 
group per sex ) for testes , ovary and uterus for Control and treatment groups were 
compared statistically using one way ANOVA followed by Dunnett‟s test. 
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Histopathological analysis (Female Rat) in Sub-acute toxicity Study 
                                         Low Power Magnification 10X 
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Histopathological analysis (Female Rat) in Sub-acute toxicity Study 
High Power Magnification 40X 
        Group I            Group II              Group III 
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Histopathological analysis (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
                           Group I         Group II                 Group III 
 
Brain 
   
 
 
 
 
Heart  
 
 
 
 
 
Kidney   
 
 
 
 
Liver 
 
 
 
 
 
110 
 
Histopathological analysis (Male Rat) in Sub-acute toxicity Study 
 High Power Magnification 40X 
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HISTOPATHOLOGY REPORT 
BRAIN  
Appearance of inter neuronal space and count appears normal with regular 
morphology of brain parenchymal cells. No signs of degeneration and hemorrhage were 
observed in sample belongs to group I,II and III. 
HEART  
Myocardial fiber mass appears denser with no signs of degeneration or fibrosis 
were observed in samples belongs to group I, II and III. 
LUNG 
Light microscopic examination of lung revealed normal alveoli and alveolar sac 
with no signs of infiltration in both control and treated rats. 
STOMACH  
Light microscopic observation stomach reveals normal histology of gastric wall 
composed of normal mucosa, muscularismucosa, submucosa, muscularispropiria and 
adventitia. No signs of ulceration were observed in sample belongs to group I, II and III. 
LIVER  
Cytoplasm appears normal with widen portal tract. Hepatocellular architecture was 
normal with no signs of necrosis .A considerable number of Kupffer cells are observed in 
the sinusoid walls were observed in in sample belongs to group I, II and III. 
SPLEEN  
Appearance of central artery and marginal sinus are normal . Lymphoid follicles 
appears normal . Marginal sinus (MS) of the rat and its sinus lining cells appears normal. 
Erythropoietic cells (EP) are scattered throughout the red pulp of sample belongs to group 
I, II and III. 
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KIDNEY  
Lumen of vessels and bowman‟s space appears normal. Glomerular basement 
membrane appears normal. Epithelial lining on proximal convoluted tubule appears 
normal in sample belongs to group I,II and III. 
TESTES  
Presence of mature somatic cells project the perfect histomorphology of testicular 
cells in this group. Primary spermatocytes with large centered nucleus and dense 
chromatin were observed in sample belongs to group I,II and III. 
UTERUS 
Appearance of endometrium, myometrium and uterine glands was normal. 
Arrangement of stratum basale, functionale and surface epithelium seems normal in 
samples belongs to group I,II and III. 
OVARY  
Histopathological analysis of ovary showing normal corpus luteum (CL) and 
Primordial follicles with few mature ovarian follicles with no signs of abnormality. 
Appearance of antral follicle, primary oocyte and secondary follicles are normal in sample 
belong to group I,II and III. 
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Molecular Docking Study Report 
Name of the Client: Dr. Sumathi 
Purpose: Computational Analysis  
Project ID : NRS/AS/0019/01/2017 
Formulation : Oma Legium 
Indication : Scabies/ Immuno Modulatory/ Anti Allergic 
Source: Trachyspermum Ammi 
Phyto 
Components 
Action Reference 
Beta pinene Anti-Microbial https://www.ncbi.nlm.nih.gov/pubmed/22634841 
 
Anti-scabies http://www.rjpbcs.com/pdf/2014_5(3)/[154].pdf 
Thymol Anti-Bacterial https://www.ncbi.nlm.nih.gov/pubmed/7938073 
 
Antioxidant https://core.ac.uk/download/pdf/11978224.pdf 
 
Mast cell 
inhibitor- 
Immunomodulato
ry 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040322/ 
 
Anti-allergic and 
anti-
inflammatory 
http://pubs.sciepub.com/ajmbr/1/4/4/ 
 
Anti-Fungal 
https://bmccomplementalternmed.biomedcentral.com/articles/
10.1186/s12906-015-0947-2 
 
Anti-scabies http://www.rjpbcs.com/pdf/2014_5(3)/[154].pdf 
Carvacrol Anti-Microbial 
http://www.microbiologyresearch.org/docserver/fulltext/jmm/
56/4/519.pdf?expires=1494922941&id=id&accname=guest&c
hecksum=1310A657AC3DC34560A298784FF27E42 
 
Anti-allergic and 
anti-
inflammatory 
http://online.liebertpub.com/doi/abs/10.1089/jmf.2012.0102 
 
Anti-scabies http://www.rjpbcs.com/pdf/2014_5(3)/[154].pdf 
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Compounds / Drug Selected for Docking based on literature 
 Beta pinene 
 Carvacrol 
 Thymol  
Receptors / Target protein Selected for Docking 
Name of the Protein PDB code Standard antagonist 
Histamine 1 receptor 3RZE Cetirizine 
Prostaglandin H2 
synthases 
1igx Salycilic acid 
Cyclooxygenase I 3KK6 Ibuprofen 
Cyclooxygenase 2 6COX   Celecoxib 
 
Methodology 
Docking calculations were carried out using Auto Dock 4. Gasteiger partial 
charges were added to the ligand atoms. Non-polar hydrogen atoms were merged, and 
rotatable bonds were defined. Docking calculations were carried out for test drug Beta 
pinene, Carvacrol, Thymol and standard Cetirizine, Salycilic acid, Ibuprofen and 
Celecoxib against target protein protein model. Essential hydrogen atoms, Kollman 
united atom type charges, and solvation parameters were added with the aid of AutoDock 
tools (Morris, Goodsell et al., 1998). Affinity (grid) maps of ×× Å grid points and 0.375 
Å spacing were generated using the Autogrid program (Morris, Goodsell et al., 1998). 
AutoDock parameter set- and distance-dependent dielectric functions were used in the 
calculation of the van der Waals and the electrostatic terms, respectively. Docking 
simulations were performed using the Lamarckian genetic algorithm (LGA) and the Solis 
& Wets local search method (Solis and Wets, 1981). Initial position, orientation, and 
torsions of the ligand molecules were set randomly. All rotatable torsions were released 
during docking. Each docking experiment was derived from 2 different runs that were set 
to terminate after a maximum of 250000 energy evaluations. The population size was set 
to 150. During the search, a translational step of 0.2 Å, and quaternion and torsion steps of 
5 were applied. 
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Final Docking result Analysis 
Cyclooxygenase 1 Receptor 
R
a
n
k
 
A
m
in
o
 
A
ci
d
 
in
te
ra
ct
io
n
 
C
o
m
p
o
u
n
d
 
A
m
in
o
 
A
ci
d
 
S
eq
u
en
ce
 
  10 
Ibuprof
en 205 PHE 
209 
PHE 
348 
TYR 
352 
LEU 
381 
PHE 
385 
TYR 
387 
TRP 
518 
PHE 
530 
SER 
534 
LEU  
1 6 
Beta 
Pinene 352 LEU 
381 
PHE 
384 
LEU 
385 
TYR 
387 
TRP 
518 
PHE 
530 
SER       
2 4 
Carvacr
ol 349 VAL 
384 
LEU 
385 
TYR 
387 
TRP 
518 
PHE 
523 
ILE 
527 
ALA 
530 
SER 
531L
EU   
 
 
0 0 Thymol 
No 
Interactio
n 
          
Out of three compound‟s Betapinene has 6 interactions (60%) similar to that of the 
standard Ibuprofen  hence it has promising  COX 1 inhibition activity similarly other compound 
Carvacrol  has  40% percentage similar interaction to that of the standard hence both compounds 
has COX 1 inhibition activity. Compound Thymol has no COX1 inhibition activity. 
Cyclooxygenase 2 Receptor 
Rank 
Amino Acid 
interaction 
Compound Amino Acid Sequence 
 
5 Celecoxib 54 GLN 55 TYR 56 LYS 57 CYS 67 GLU 
1 3 Betapinene 55 TYR 56 LYS 67 GLU 
  
1 3 Carvacrol 54 GLN 55TYR 67GLU 
  
2 1 Thymol 35 PRO 37 CYS 38 SER 55 TYR 165 VAL 
 
Out of three compound‟s Betapinene and Carvacrol has 3 interactions (60%) similar to 
that of the standard Celecoxib hence it has promising COX 2 inhibition activity similarly other 
compound Thymol  has 20% percentage similar interaction to that of the standard hence all three 
compounds has promising COX 2 inhibition activity. 
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Histamine 1 Receptor 
Ra
nk 
Amin
o 
Acid 
inter
actio
n 
Com
poun
d 
Amino Acid Sequence 
  15 
Citraz
ine 
84 
AS
N 
103 
TRP 
107 
ASP 
108 
TYR 
111 
SER 
158 
TRP 
179 
LYS 
194 
THR 
424 
PHE 
428 
TRP 
431 
TYR 
432 
PHE 
435 
PHE 
454 
ILE 
458 
TYR 
3 4 
Betap
inene 
108 
TYR 
111 
SER 
112 
THR 
115 
ILE 
198 
AS
N 
424 
PHE 
432 
PHE                 
1 8 
Carva
crol 
107 
ASP 
108 
TYR 
111 
SER 
115 
ILE 
158 
TRP 
198 
AS
N 
199 
PHE 
424 
PHE 
428 
TRP 
431 
TYR 
432 
PHE         
2 7 
Thym
ol 
107 
ASP 
108 
TYR 
111 
SER 
112 
THR 
115 
ILE 
199 
PHE 
424 
PHE 
428 
TRP 
431 
TYR 
432 
PHE           
Out of three compound‟s Carvacrol has  8 interactions (53%) similar to that of the standard 
Citrazine hence it has Histamine 1 Receptor inhibition activity similarly other two compounds 
thymol has 46% percentage and Betapinene has 26% similar interaction to that of the standard 
hence all three compounds has promising Histamine 1 receptor inhibition activity. 
Prostaglandin Synthase 
Rank 
Amino Acid 
interaction Compound 
Amino Acid Sequence 
  5 Salicylic acid  35 PRO 38 TYR 40 PRO 54 ARG 55 TYR 
3 1 Betapinene 55 TYR 67 PRO 68 ASN     
1 4 Carvacrol 35 PRO 38 TYR 40 PRO 55 TYR   
2 2 Thymol 54 ARG 55 TYR 67 PRO 68 ASN   
 
Out of three compound‟s Carvacrol has 4 interactions (90%) similar to that of the standard 
Citrazine Salicylic acid hence it has Prostaglandin Synthase inhibition activity similarly other two 
compounds thymol has 40% percentage and Betapinene has 20% similar interaction to that of the 
standard hence all three compounds has promising Prostaglandin Synthase inhibition activity. 
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Conclusion 
Based on the results of the computational analysis it was concluded that the 
compound’s such as Betapinene, Thymol , Carvacrol  present in the formulation Oma 
Legium  possess significant inhibition of COX 1& 2 ,Prostaglandin synthases and Histamine 
1blocking activity there it was concluded that this formulation may have promising anti-
inflammatory, anti-allergic, immune modulatory activity  
Purpose: Anti- Microbial Profiling 
Project Id: NRS/AS/0019/01/2017 
Total Sample: 01  
Sample ID:   OL 
Institute: Govt Siddha Medical College, Chennai 
Disc-diffusion method:  
The antibacterial activities of the sample OL were carried out by disc diffusion 
method.  The concentrations of the test compounds were used at the concentration of 100, 
200, 300 µg. The target microorganisms were cultured in Mueller–Hinton broth (MHB). 
After 24 h the suspensions were adjusted to standard sub culture dilution. The Petri dishes 
containing Muller Hinton Agar (MHA) medium were cultured with diluted bacterial 
strain. Disc made of Whatman No.1, diameter 6 mm was pre-sterilized and was 
maintained in aseptic chamber. Each concentration was injected to the sterile disc papers. 
Then the prepared discs were placed on the culture medium. Standard drug Ciprofloxacin 
(5µg) for anti-bacterial and Fluconazole (25µg) was used as a positive reference standard 
to determine the sensitivity of each microbial species tested. Then the inoculated plates 
were incubated at 37
o 
C for 24 h (Bacterial) - 72 hr (Fungal). The diameter of the clear 
zone around the disc was measured and expressed in millimeters as its anti-microbial 
property. The results were depicted in Table. 
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Organisms used for Anti-Bacterial Activity 
s.no organisms Type 
1.  Staphylococcus aureus Gram-positive 
2.  Streptococcus pyogenes Gram-positive 
 
Organisms used for Anti-Fungal Activity 
s.no organisms 
1.  Candida albicans 
2.  Aspergillus niger 
 
Zone of Inhibition data of Anti-Microbia activity  
 
Sample 
Code 
Streptococcus 
pyogenes 
Staphylococcus 
aureus 
Candida albicans Aspergillus niger 
Concentrai
on 
100 
µg 
200 
µg 
300  
µg 
100 
µg 
200 
µg 
300  
µg 
100 
µg 
200 
µg 
300  
µg 
100 
µg 
200 
µg 
300  
µg 
OL 2 4 9 - - - - - - - - - 
Ciprofloxa
cin (5µg) 
25 26 NA NA 
Fluconazol
e (25µg) 
NA NA 19 16 
-  =  Not active 
NA = Not Applicable 
Conclusion 
From the results of the present study it was concluded that the sample OL was 
effective against   Streptococcus pyogenes  and not active against Staphylococcus aureus  
Candida albican and Aspergillus niger. 
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Anti- Microbial Effect of OL against 
Staphylococcus aureus 
Anti- Microbial Effect of OL  against 
Streptococcus pyogenes 
Anti-Bacterial Evaluation of OL 
 
 
 
 
 
 
 
 
 
 
 
 
ANTI-FUNGAL EVALUATION 
 
 
 
  Anti- Microbial Effect of OL     Anti- Microbial Effect of OL 
   against Candida albicans      against Aspergillus niger 
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BIO – STATISTICS 
Treatment for sirangu(Scabies): 
   The most popular non parametric statistical tool, namely, McNemar Test analysis has 
been employed to analyses the effectiveness with the help of a hypothesis. 
S.NO Clinical Features 
Before Treatment After Treatment 
n% n% 
1. Nocturnal Itching 40(100) 3(7.5)** 
2. Burrow 4(100) 2(5)** 
3. Pruritic Papules 30(75) 3(7.5)** 
4. Pustules 27(67.5) 0(0)** 
5. Papulo Vesicules 17(42.5) 0(0)** 
Mc Nemat test, C.I:95%, * P<0.05; ** P<0.01 
 
Software: spss17version 
Number of cases: 40 
Inference: 
Since the p value is significant in all clinical features. So there is significant 
reducing of clinical features among the patients for the treatment of sirangu(Scabies). 
Hence it is concluded that the treatment was effective and significant. 
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106                                                                                                          
POST- GRADUATE DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
CLINICAL STUDY ON “OMA LEGIUM & MUSUTTAI ENNAI” IN THE 
TREATMENT “SIRANGU’’ (SCABIES IN CHILDREN). 
FORM l - SCREENING AND SELECTION PROFORMA 
 
1. OP NO: 
2. NAME:  
3. AGE:                  4.GENDER 
5. F.OCCUPATION                                                         6. F.INCOME:   
7. ADDRESS:     
 
8. CONTACT NO:             
 INCLUSION CRITERIA: 
Age:  3-7 Yrs.                  Yes/No 
Nocturnal itching.                                                     Yes/No 
Pruritic papules                                                         Yes/No 
Burrow                                                                      Yes/No  
Pustules          Yes/No 
Papulo vesicles      Yes/No                                                                                                                                                                                
Lesion seen in 
            Web of hand                                                          Yes/No                                                                                                 
             Wrist                                                                     Yes/No                                                                                                       
              Ulnar aspect of forearm.                                     Yes/No                                                                                                       
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              Elbow                                                                        Yes/No                                                                                                       
               Axillae                                                                      Yes/No                                                                                                       
               Feet                                                                           Yes/No                                                                                                       
              Buttock                                                                      Yes/No                                                                                                       
               Palms                                                                        Yes/No                                                                                                       
               Genital area                                                              Yes/No                                                                                                       
                Sole                                                                         Yes/No                                                                                                       
Patients who are willing to undergo Laboratory investigation.    
                                                   Yes / No 
Patients who are willing to sign the informed consent stating that she will 
conscientiously stick to the treatment during 21 days but can opt out of the trial of her 
own conscious discretion.                                                  Yes / No 
                
EXCLUSION CRITERIA 
  
ADMITTED TO TRIAL: 
                         YES                        NO                 
      If  YES,             OPD/IPD                    
Date:        
Station: 
 
Signature of the Guide                                   Signature of the Investigator  
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106                                                                                                            
POST- GRADUATE DEPARTMENT OF KUZHANTHAI MARUTHUVAM  
CLINICAL STUDY ON ““OMA LEGIUM & MUSUTTAI ENNAI” IN THE 
TREATMENT OF “SIRANGU’’ (SCABIES IN CHILDREN) 
FORM lI -HISTORY TAKING PROFORMA 
1. SERIAL NO OF THE CASE: …….  2.OP  NO: .................................................... 3. 
NAME: ………………………………………… 4. AGE: ……..  
5. GENDER: …….. 
5. F. OCCUPATION: ……………………………… 
6.F. INCOME:   ………………….. 
7. COMPLAINTS & DURATION:   
                                                                                                                                                           
8. PERSONAL HISTORY: 
9. HISTORY OF PREVIOUS ILLNESS: 
10. BIRTH HISTORY: 
11. DIETARY HABIT:     
             1. Vegetarian              
             2. Non-vegetarian 
12. FAMILY HISTORY: 
               Whether this problem runs in family? 
                                         1. Yes                               2.No         
               If yes, mention the relationship of affected person(s) --------------------- 
               History of previous investigations if any ------------------------------ 
Signature of the Guide                                    Signature of the Investigator   
Date:        
Station: 
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106                                                                                                         
POST- GRADUATE DEPARTMENT OF KUZHANTHAI MARUTHUVAM   
CLINICAL STUDY ON “OMA LEGIUM & MUSUTTAI ENNAI” IN THE 
TREATMENT “SIRANGU’’ (SCABIES IN CHILDREN) 
FORM III ASSESSMENT PROFORMA 
 
1. SERIAL NO: …………………   
2. OP  NO: ......................................   
3. NAME: ……………………………   4.AGE: ……     5.GENDER: .................            
GENERAL EXAMINATION: 
Height (cms)                : ………………………….                   
Weight (kg)    : ………………………….                   
Temperature (°F)     : ………………………….                   
Pulse rate (/min)   : ………………………….                   
Heart rate (/min)   : ………………………….                   
Respiratory rate (/min)  : ………………………….                   
Blood pressure (mm/Hg)                 : ………………………….           
   Present          Absent 
Pallor  
Jaundice 
Cyanosis 
Lymphadenopathy 
Pedal edema 
Clubbing                                              
Jugular vein pulsation 
SYSTEMIC EXAMINATION 
Cardio Vascular System  : ………………………….                   
Respiratory system   : ………………………….                   
Gastro-intestinal system  : ………………………….                   
Central Nervous System  : ………………………….                   
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Urogenital system   : ………………………….                   
Endocrine System   : ………………………….                   
SIDDHA SYSTEM OF EXAMINATIONS: 
1. THEGI:  [BODY CONSTITUTION]  
1. Vatha udal 
2. Pitha udal 
3. Kaba udal 
4. Thontha udal       
2. NILAM:  [LAND WHERE PATIENT LIVED MOST] 
   1. Kurinji    (Hilly terrain)                                   
   2. Mullai    (Forest range)                       
    3. Marutham    (Plains)                            
4. Neithal     (Coastal belt)                    
5. Paalai  (Arid regions) 
3. KAALAM: 
1. Kaar kaalam                               4.Pinpani kaalam      
2. Koothir kaalam                           5. Ilavenil kaalam 
3. Munpani kaalam                           6.Muthuvenil kaalam 
4. GUNAM: 
           1. Sathuvam                
 2. Raasatham              
3. Thaamatham 
5. IMPORIGAL (SENSORY ORGANS): 
                                                                        Normal/Affected 
Mei       ----------------------------------------------- 
Vaai       ----------------------------------------------- 
Kann      ------------------------------------------------ 
Mukku   ------------------------------------------------ 
Sevi        ------------------------------------------------ 
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6. KANMENDHIRIYAM (MOTOR ORGANS): 
Kai        ----------------------------------                
Kal        ------------------------------------ 
Vaai       ------------------------------------ 
Eruvai    ---------------------------------- 
Karuvaai  --------------------------------- 
7. KOSANGAL (SHEATH): 
Annamaya kosam       ---------------------------- 
Pranamaya kosam      --------------------------  
Manomaya kosam      --------------------------- 
Vignana maya kosam --------------------------- 
Anandamaya kosam    ------------------------- 
8. UYIR THAATHUKKAL: [THREE HUMORS] (VALI, AZHAL, IYAM) 
A) VALI 
 Pranan –------------------------------------------------------------------------ 
Abanan ------------------------------------------------------------------------- 
Samanan ----------------------------------------------------------------------- 
Uthanan ------------------------------------------------------------------------ 
Vyanan -------------------------------------------------------------------------- 
Naagan -------------------------------------------------------------------------- 
Koorman ------------------------------------------------------------------------ 
Kirukaran----------------------------------------------------------------------- 
Devathathan ------------------------------------------------------------------- 
Dhananjayan ------------------------------------------------------------------ 
B) AZHAL 
Analakam -------------------------------------------------------- 
Ranjakam --------------------------------------------------------- 
Sathakam ---------------------------------------------------------- 
Prasakam ----------------------------------------------------------- 
Alosakam ------------------------------------------------------------ 
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C) IYAM 
Avalambagam ------------------------ 
Kilethagam --------------------------- 
Pothagam ------------------------------ 
Tharpagam ---------------------------- 
Santhigam ------------------------------ 
9. SEVEN UDAL THATHUKKAL: (SEVEN SOMATIC COMPONENTS)  
Saram ------------------------------------------ 
Senneer --------------------------------------- 
Oon --------------------------------------------- 
Koluppu ---------------------------------------- 
Enbu --------------------------------------------- 
Moolai ------------------------------------------- 
Sronitham -------------------------------------- 
10. ENVAGAI THERVU: 
  I. NAADI: [PULSE PERCEPTION]         
             II. SPARISAM: [PALPATION} 
             III. NAA: [TONGUE] 
 IV.NIRAM: [COMPLEXION]   
    1. Vatham         
     2. Pitham 
      3. Kabam  
             V.MOZHI: [VOICE] 
            1. High Pitched 
            2. Low Pitched 
                        3. Medium Pitched 
             VI.VIZHI: [EYES] 
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VII. MALAM: [BOWEL HABITS / STOOLS] 
Niram 
Irugal 
Ilagal 
Others 
 VIII. MOOTHIRAM [URINE EXAMINATION]   
NEERKKURI: 
Niram 
Manam 
Edai 
Nurai 
Enjal 
NEIKKURI 
 
Signature of the Guide                                             Signature of the Investigator   
Date:        
Station: 
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
POST- GRADUATE DEPARTMENT OF KUZHANTHAI MARUTHUVAM  
CLINICAL STUDY ON “OMA LEGIUM & MUSUTTAI ENNAI” IN THE 
TREATMENT OF “ SIRANGU’’ (SCABIES IN CHILDREN) 
FORM IV: LABORATORY INVESTIGATIONS PROFORMA 
1. SERIAL NO OF THE CASE: …………………   
2. OP  NO: ......................................   
3. NAME: ……………………………   4.AGE: ……     5.GENDER: .................   
A) BLOOD INVESTIGATIONS:                        
BLOOD INVESTIGATIONS BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Hb ( gm/dL)   
ESR (mm) ½ hr.   
  1 hr.   
T.WBC (Cells / Cu.mm)   
Differential 
Count (%) 
Polymorphs   
  Lymphocytes   
  Monocytes   
  Eosinophils   
  Basophils   
B) URINE INVESTIGATIONS: 
URINE 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
          Albumin   
          Sugar   
Deposits   
 
Signature of the Guide                                             Signature of the Investigator    
Date:        
Station: 
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
POST- GRADUATE DEPARTMENT OF KUZHANTHAI MARUTHUVAM  
CLINICAL STUDY ON “OMA LEGIUM & MUSUTTAI ENNAI”  IN THE 
TREATMENT OF   “SIRANGU’’ (SCABIES IN CHILDREN) 
FORM V: INFORMED CONSENT FORM 
“I have read the foregoing information, or it has been read to me. I have had 
the opportunity to ask questions about it and any questions I have asked have been 
answered to my satisfaction. 
            I   consent voluntarily to participate my child in this study and understand that I 
have the right to withdraw from the study at any time without in any way it affecting my 
child further medical care”. 
"I have received a copy of the information sheet/consent form". 
Date: 
Signature of the participant: 
In case of illiterate participant 
  “I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has had the opportunity to ask questions. I confirm that 
the individual has given consent freely.”                                                   
Date: 
Signature of a witness                                     Left thumb Impression of the Participant     
(Selected by the participant bearing no connection with the survey team)       
Date:    
Station:                                                                                  
Signature of participant:                                                 
 Signature of the Guide:                                               Signature of the Investigator:   
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muR rpj;j kUj;Jtf; fy;Y}Hp> nrd;id-106 
mwpQh; mz;zh kUj;Jtkid> nrd;id 
rpuq;F Neha;f;fhd rpj;j kUe;jpd; (Xk Nyfpak; & KRl;il vz;nza;) 
ghpfhpg;Gj; jpwidf; fz;lwpAk; kUj;Jt Ma;tpw;fhd jfty; gbtk; 
          Xg;Gjy; gbtk; Ma;thsuhy; rhd;wspf;fg;gl;LJ. 
     ehd; ,e;j Ma;it Fwpj;j midj;J tpguq;fisAk; Nehahspf;F GupAk; 
tifapy; vLj;Jiuj;Njd; vd cWjpaspf;fpNwd;. 
Njjp:                            ifnahg;gk;: 
,lk;:                            ngah;:  
Nehahspapd; ngw;Nwhh; xg;Gjy; gbtk;  
vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk;> kUe;jpd; jd;ik kw;Wk; 
kUj;Jt topKiw gw;wpAk;> njhlh;e;J vdJ cly; ,af;fj;ij fz;fhzpf;fTk;> 
mjid ghJfhf;fTk;; gad;gLk; kUj;Jt Ma;Tf;$l ghpNrhjidfs; gw;wp jpUg;jp 
mspf;Fk; tifapy; Ma;T kUj;Jtuhy; tpsf;fpf; $wg;gl;;lJ. 
ehd; vdJ Fo;e;ijapd; ,e;j kUj;Jt Ma;tpd; NghJ fhuzk; vJTk; 
$whky;> vg;nghOJ Ntz;LkhdhYk; ,e;j Ma;tpypUe;J vdJ Foe;ijia 
tpLtpj;J nfhs;Sk; cupikia njupe;jpUf;fpd;Nwd;. ehd; vd;Dila Rje;jpukhf 
Njh;T nra;Ak; cupikiaf; nfhz;L Neha;f;fhd  kUe;jpd; ghpfhpg;Gk; (Xk 
Nyfpak; & KRl;il vz;nza;)   jpwidf; fz;lwpAk; kUj;Jt Ma;tpw;F vd;id 
cl;gLj;j xg;Gjy; mspf;fpNwd;.  
Njjp:                            ifnahg;gk;: 
,lk;:                            ngah;:  
Njjp:                            rhl;rpf;fhuh; ifnahg;gk;: 
,lk;:                            ngah;:  
cwTKiw: 
 
Jiwj;jiyth; ifnahg;gk;:           Muha;r;rpahsh; ifnahg;gk;:   
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE         
CHENNAI – 600 106 
POST- GRADUATE DEPARTMENT OF KUZHANTHAI MARUTHUVAM                                                                                                                     
CLINICAL STUDY ON “OMA LEGIUM & MUSUTTAI ENNAI” IN THE 
TREATMENT OF “SIRANGU’’ (SCABIES IN CHILDREN) 
FORM VI - WITHDRAWAL FORM 
SI NO:                 
OP  NO:                                               
NAME: 
AGE / GENDER:                
DATE OF TRIAL COMMENCEMENT: 
DATE OF WITHDRAWAL FROM TRIAL: 
REASONS FOR WITHDRAWAL: 
• Long absence at reporting :                                    Yes/ No 
• Irregular treatment:                                                Yes/ No 
• Shift of locality :                                                    Yes/No 
• Increase in severity of symptoms:                         Yes/No 
• Development of severe adverse drug reactions:    Yes/No 
 
Signature of the Guide                                            Signature of the Investigator   
 
Date:        
Station: 
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                          GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
POST- GRADUATE DEPARTMENT OF KUZHANTHAI MARUTHUVAM   
CLINICAL STUDY ON ““OMA LEGIUM & MUSUTTAI ENNAI”  IN THE 
TREATMENT OF “SIRANGU’’ (SCABIES  IN CHILDREN) 
FORM VII – PATIENT INFORMATION SHEET 
Name of Co- Investigator: Sumathi.M   Name of the college:  Govt.Siddha. Medical                  
College                                                                                      
                                                                                                      Arumbakkam 
                                                                                                       Chennai-106. 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
CLINICAL TRIAL. 
       I M.Sumathi studying M.D (Siddha) at Govt.Siddha Medical College, Chennai, is 
doing a clinical trial on „„Sirangu -Scabies in children. It is becoming a most common 
disease, occurring throughout the world. In this regard, I am in need to ask you few 
questions. I will maintain confidentiality of your comments and data obtained. There will 
be no risk of disclosing your identity and no physical, psychological or professional risk 
is involved by taking part in this study. Taking part in this study is voluntary. No 
compensation will be paid to you for taking part in this study. 
           You can choose not to take part. You can choose not to answer a specific question. 
There is no specific benefit for you if you take part in the study. However, taking part in 
the study may be of benefit to the community, as it may help us to understand the problem 
of defaulters and potential solutions. 
             If you agree to be a participant in this study, you will be included in the study 
primarily by signing the consent form and then you will be given the internal medicine 
“OMA LEGIUM” (Internal medicine) 5gm /twise a day “MUSUTTAI ENNAI” 
(External medicine)  for 21 days.  
  The information I am collecting in this study will remain between you and the Co- 
investigator (myself). I will ask you few questions through a questionnaire. I will not 
write your name on this form. I will use a code instead.The questionnaire will take 
approximately 20 minutes of your time. 
If you wish to find out more about this study before taking part, you can ask me all 
the questions you want or contact M.Sumathi, PG Scholar cum Co- investigator of this 
study, attached to Govt. Siddha Medical College, Chennai-106. You can also contact the 
Member-secretary of Ethics committee, Govt.Siddha Medical College, Chennai. 
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muR rpj;j kUj;Jtf; fy;Y}Hp> nrd;id-106 
mwpQh; mz;zh kUj;Jtkid> nrd;id 
rpuq;F Neha;f;fhd rpj;j kUe;jpd; (Xk Nyfpak; & KRl;il vz;nza;)    
ghpfhpg;Gj; jpwidf; fz;lwpAk; kUj;Jt Ma;tpw;fhd jfty; gbtk; 
 
Muha;r;rpahsh; ngau;: kh Rkjp 
epWtdj;jpd; ngau;:muR rpj;j kUj;Jtf; fy;Y}up 
               mUk;ghf;fk;> nrd;id-106 
muR rpj;j kUj;Jtf; fy;Y}upapy; gl;lNkw;gbg;G gapd;W tUk; ehd; 
kUj;Jtu; Nfh.Qh.fiyr;nry;tp rpuq;F vd;Dk; Nehapy; kUj;Jt Muha;r;rpapy; 
<Lgl;Ls;Nsd;. 
    ,e;j Neha; fpUkpfspdhy; Vw;gLfpd;wd. ,J gutf; $ba Neha;. 
    ,e;j Muha;r;rp rk;ge;jkhf rpy Nfs;tpfisf; Nfl;fTk;> Njitahd 
Ma;tfg; gupNrhjidf;F jq;fs; Foe;ijia cl;gLj;jTk cs;Nsd;. 
   ,e;j Muha;r;rpf;F jq;fs; tpUg;gj;jpd; Ngupy; cl;gLk; gl;rj;jpy; cs;kUe;ehf 
Xk Nyfpak;; 5gm/twise a day, ntspkUe;jhf KRl;il vz;nza; gad;gLfpd;wJ. 
    ,e;j kUe;J rpwg;ghf   rpuq;F Neha;f;fhf mq;fPfupf;fg;gl;l rpj;j kUj;Jt 
E}ypy; $wg;gl;Ls;sJ  
    ,e;j Muha;r;rpapy; jq;fis mDkjpj;j gpwF cq;fSf;F tpUg;gk; 
,y;iynadpy; vg;NghJ Ntz;LkhdhYk; Muha;r;rpapy; ,Ue;J tpyfpf; nfhs;s 
cupik cs;sJ. 
    ,e;j Muha;r;rpf;F rk;ge;jkhf Nehapd; jd;ik gw;wpAk; kw;w tpguq;fSf;Fk; 
Muha;r;rpahsu; kUj;Jtu;: kh Rkjp (gl;lNkw;g; gbg;ghsu;> Foe;ij kUj;Jtj; 
Jiw) mtu;fis ve;j Neuj;jpYk; njhlu;G nfhs;syhk;. ifg;Ngrp vz;: 
9176973238. NkYk; ,e;j Muha;r;rpf;F jf;f mDkjpr; rhd;W (IEC) ngwg;gl;Ls;sJ. 
   ,e;j kUe;J Kw;wpYk; ghJfhg;ghd %ypif nghUl;fisf; nfhz;L 
jahhpf;fg;gl;Ls;sJ. gf;f tpisTfis Vw;gLj;jhJ. NkYk; czT Kiwapy; 
kUj;Jtuhy; $wg;gLk; gj;jpak; fhf;FkhW mwpTWj;jgLfpwJ. 
      ,J rk;gjkhd jq;fsJ midj;J tptuq;fSk; ufrpakhf itf;fg;gLk; 
vd cWjp mspf;fpNwd;. 
      ,jpy; gazg;gb Kjypa ve;j cjtpj; njhifAk; toq;fg;glkhl;lhJ. 
,e;j Muha;r;rpapd; NghJ clYf;F NtW ghjpg;G Vw;gLk; gl;rj;jpy; mwpQu; 
mz;zh kUj;Jtkidapy; jf;f rpfpr;ir mspf;fg;gLk;. 
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
POST- GRADUATE DEPARTMENT OF KUZHANTHAI MARUTHUVAM  
CLINICAL STUDY ON “OMA LEGIUM & MUSUTTAI ENNAI” IN THE 
TREATMENT OF “SIRANGU’’ (SCABIES IN CHILDREN) 
FORM X - ADVERSE REACTION REPORTING FORM 
 
SERIAL NO:                                                                                                           
OP/IP NO: 
NAME:                                                    AGE:                                          GENDER: 
DATE OF TRIAL COMMENCEMENT: 
DATE OF OCCURRENCE OF THE ADVERSE REACTION:  TIME: 
DESCRIPTION OF ADVERSE REACTION: 
 
 
MANAGEMENT: 
Signature of the Guide                                             Signature of the Investigator   
 
Date:        
Station: 
 
 
 
 
 
136 
 
DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
DISSERTATION STUDY ON OMA LEGIUM (INT) &MUSUTTAI ENNAI (EXT) 
IN    SIRANGU (SCABIES) 
Investigator: Dr.M.SUMATHI. Place: Arignar Anna Hospital, Chennai-600106. 
OP NO/:                                 DATE:   
NAME            :                AGE/SEX:  
PARENT NAME: 
ADDRESS:    
PHONE NO                                 :   
COMPLAINS AND DURATION  
 NOCTURNAL ITCHING: 
 BURROW                        :  
 PUSTULE                        :  
 PAPULOVESICLES       : 
 PRURITIC PAPULES     : 
 LESION SEEN IN           :   
MODE OF ONSET                     :                                             ACUTE/CHRONIC  
ECONOMIC STATE                  :                                              POOR/MIDDLE/RICH  
DIET                                            :                                              VEG/MIXED   
PAST HISTORY:   
FAMILY HISTORY:     
ON EXAMINATION:  
CVS  :  
RS  :  
HT  :  
WT :  
   
ENVAGAI THERVU:  
NAA:    MALAM:  
NIRAM:   MOOTHIRAM:  
MOZHI:    NAADI:  
VIZHI:   SPARISAM:  
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INVESTIGATIONS:  
  
SAMPLE BEFORE TREATMENT AFTER TREATMENT  
BLOOD  
TC      
DC      
ESR      
HB      
URINE    
ALB      
SUG      
DEP      
OTHERS       
 
TREATMENT:  
   
DATE 
NOCTURNAL 
ITCHING 
BURROWS 
PAPULO 
VESICLES 
PRURITIC 
PAPULES 
PUSTULES 
 
M.O 
SIGN 
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GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
CHENNAI 
Branch -IV KUZHANTHAI MARUTHUVAM 
PROFORMA OF CASE SHEET FOR SIRANGU 
 
IP. No  :     Nationality  : 
Name   :     Religion  : 
Age   :     Date of Admission : 
Sex   :     Date of Discharge : 
Address    :     Diagnosis  : 
Informant  :     Medical Officer : 
1. Complaints and duration   : 
2. History of present illness   : 
3. History of Past illness   : 
4. Antenatal history   : 
5. Birth history    : 
6. Neonatal history   : 
7. Developmental  history  : 
8. Nutritional  history   : 
9. Immunization history   : 
10. Family history    : 
11. Socio economic status  : 
General examination 
 1. Appearance and posture   : 
 2. Nutritional status    : 
3. Anaemia     : 
4. Cyanosis     : 
5. Clubbing     : 
6. Jaundice     : 
7. Lymphadenopathy    :    
8. Abdominal distension   : 
9. Pedal oedema    : 
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Vital Signs 
1. Temperature    : 
2. Pulse rate     : 
3. Respiratory rate    : 
4. Heart rate     : 
5.  Blood pressure       : 
Anthropometry 
a. Height   : 
b. Weight   : 
c .Chest circumference : 
SIDDHA ASPECTS  
 Nilam 
1. Kurinji   : 
2. Mullai   : 
3. Marutham   : 
4. Neithal   : 
5. Paalai    : 
Paruvakalam 
1. Kaar    : 
2. Koothir   : 
3. Munpani   : 
4. Pinpani   : 
5. Elavenil   : 
6. Muthuvenil    : 
 
Poripulangal   
1. Mei    
2. Vai   : 
3. Kan   : 
4. Mooku   : 
5. Sevi   : 
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Kanmenthiriyam  
1. Kai   : 
2. Kaal   : 
3. Vaai   : 
4. Eruvai   : 
5. Karuvai  : 
Uyir thathukkal  
Vadham 
1. Praanan  : 
2. Abaanan  : 
3. Viyaanan  : 
4. Uthaanan  : 
5. Samaanan  : 
6. Naagan  : 
7. Koorman  : 
8. Kirukaran  : 
9. Devathathan  : 
10. Dhananjeyan  : 
Pitham 
1. Analpitham  : 
2. Ranjagam  : 
3. Saadhagam  : 
4. Praasagam  : 
5. Aalosagam  : 
Kabam 
1. Avalambagam : 
2. Kiletham  : 
3. Pothagam  : 
4. Tharpagam  : 
5. Santhigam  : 
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Udal Kattugal 
1. Saaram  : 
2. Senneer  : 
3. Oon  : 
4. Kozhuppu : 
5. Enbu  : 
6. Moolai  : 
7. Sukkilam / Suronitham:   
Envagai Thervugal 
1. Naadi  : 
2. Sparisam : 
3. Naa  : 
4. Niram  : 
5. Mozhi  : 
6. Vizhi  : 
7. Malam  : 
8. Moothiram  : 
 
MODERN ASPECTS  
1. Respiratory System  : 
2. Cardiovascular system  : 
3. Gastro intestinal system : 
4. Central nervous system : 
5. Excretory system  : 
Laboratory investigations  
Blood 
TC   : 
DC   : 
ESR  : 
1
/2 hr  : 
1 hr  : 
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Hb%  : 
Urine 
 Albumin  : 
Sugar   : 
Deposits : 
Stools 
Ova  : 
Cyst  : 
Other Investigations 
Investigation - Siddha aspect 
 1. Neer kuri 
Niram   : 
Edai   : 
Manam  : 
Nurai   : 
Enjal   : 
2. Neikuri 
3. Daily progress 
Date Symptoms Medicine 
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அ஧ைிணர் ைித்஡ ஥ருத்து஬க் கல்லூரி 
       அநிஞர் அண்஠ொ இந்஡ி஦ ஥ருத்து஬஥ச஠ தைன்சண-106 
rpuq;F ல஢ொ஦ொபிகள் கசடப்திடிக்க ல஬ண்டி஦ உ஠வு ஬஫ிப௃சநகள் 
உ஠஬ில் லைர்க்க ல஬ண்டி஦ச஬ : 
 தச்சைகொய்கநிகள் 
 கீச஧஬சககள் 
 ஡ிரில஡ொடை஥ததொருட்கள் (ஏனம், ஥ஞ்ைள், ைீ஧கம், ததருங்கொ஦ம், 
஥ிபகு, சுக்கு, த஬ந்஡஦ம், பூண்டு) 
 ப௃சபகட்டி஦஡ொணி஦ங்கள் 
 த஫஬சககள் 
 ஡ண்஠ரீ் 
உ஠஬ில் ஡஬ிர்க்க ல஬ண்டி஦ச஬ 
 ஬஧கு, கம்பு, லைொபம், ஬ொச஫க்கொய், தொகற்கொய் 
 ஥ீன்஬சககள், ப௃ட்சட, கரு஬ொடு, லகொ஫ிக்கநி 
 கத்஡ரிக்கொய் 
 புபி 
 ஊறுகொய்஬சககள் 
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